Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	transcription coactivator activity	TRERF1 MED12L NCOA1 NCOA3 KMT2C NCOA6 ARID1B MAML2 DDX17 CREBBP MAML3	9.42e-12	303	39	11	GO:0003713
GeneOntologyMolecularFunction	transcription coregulator activity	TRERF1 MED12L NCOA1 NCOA3 KMT2C NCOA6 ARID1B MAML2 DDX17 SSX3 CREBBP MAML3	4.30e-10	562	39	12	GO:0003712
GeneOntologyMolecularFunction	molecular adaptor activity	TRERF1 MED12L NCOA1 NCOA3 TARDBP KMT2C NCOA6 ARID1B MAML2 DDX17 SSX3 CREBBP HERPUD1 MAML3 SGTA TNRC6A	1.59e-09	1356	39	16	GO:0060090
GeneOntologyMolecularFunction	protein-macromolecule adaptor activity	TRERF1 MED12L NCOA1 NCOA3 TARDBP KMT2C NCOA6 ARID1B MAML2 DDX17 SSX3 CREBBP HERPUD1 MAML3 TNRC6A	1.78e-09	1160	39	15	GO:0030674
GeneOntologyMolecularFunction	chromatin binding	NCOA1 NCOA3 NCOA6 HNF1A ARID1B CHD7 DDX17 RUNX1 NFAT5 CLOCK CREBBP PHC1	9.42e-09	739	39	12	GO:0003682
GeneOntologyMolecularFunction	transcription factor binding	TRERF1 MED12L NCOA1 NCOA3 NCOA6 HNF1A TAF4 RUNX1 NFAT5 CLOCK CREBBP	1.30e-07	753	39	11	GO:0008134
GeneOntologyMolecularFunction	histone acetyltransferase activity	NCOA1 NCOA3 CLOCK CREBBP	2.91e-06	51	39	4	GO:0004402
GeneOntologyMolecularFunction	transcription coactivator binding	TRERF1 HNF1A RUNX1 CREBBP	3.66e-06	54	39	4	GO:0001223
GeneOntologyMolecularFunction	peptide-lysine-N-acetyltransferase activity	NCOA1 NCOA3 CLOCK CREBBP	3.94e-06	55	39	4	GO:0061733
GeneOntologyMolecularFunction	peptide N-acetyltransferase activity	NCOA1 NCOA3 CLOCK CREBBP	5.60e-06	60	39	4	GO:0034212
GeneOntologyMolecularFunction	nuclear receptor coactivator activity	TRERF1 NCOA1 NCOA3 NCOA6	5.98e-06	61	39	4	GO:0030374
GeneOntologyMolecularFunction	peroxisome proliferator activated receptor binding	NCOA3 NCOA6 CREBBP	8.94e-06	21	39	3	GO:0042975
GeneOntologyMolecularFunction	N-acetyltransferase activity	NCOA1 NCOA3 CLOCK CREBBP	1.60e-05	78	39	4	GO:0008080
GeneOntologyMolecularFunction	N-acyltransferase activity	NCOA1 NCOA3 CLOCK CREBBP	4.60e-05	102	39	4	GO:0016410
GeneOntologyMolecularFunction	acetyltransferase activity	NCOA1 NCOA3 CLOCK CREBBP	4.96e-05	104	39	4	GO:0016407
GeneOntologyMolecularFunction	histone modifying activity	NCOA1 NCOA3 KMT2C CLOCK CREBBP	7.96e-05	229	39	5	GO:0140993
GeneOntologyMolecularFunction	DNA-binding transcription factor binding	TRERF1 NCOA1 NCOA3 NCOA6 TAF4 RUNX1 CREBBP	1.18e-04	582	39	7	GO:0140297
GeneOntologyMolecularFunction	RNA polymerase II-specific DNA-binding transcription factor binding	TRERF1 NCOA1 NCOA3 NCOA6 TAF4 CREBBP	1.46e-04	417	39	6	GO:0061629
GeneOntologyMolecularFunction	nuclear estrogen receptor binding	NCOA1 NCOA3 NCOA6	1.51e-04	53	39	3	GO:0030331
GeneOntologyMolecularFunction	transcription coregulator binding	TRERF1 HNF1A RUNX1 CREBBP	1.57e-04	140	39	4	GO:0001221
GeneOntologyMolecularFunction	RNA polymerase II transcription regulatory region sequence-specific DNA binding	NCOA1 NCOA3 TARDBP HNF1A ZFHX3 CHD7 RUNX1 NFAT5 CLOCK CREBBP	3.76e-04	1459	39	10	GO:0000977
GeneOntologyMolecularFunction	nuclear receptor binding	TRERF1 NCOA1 NCOA3 NCOA6	4.74e-04	187	39	4	GO:0016922
GeneOntologyMolecularFunction	nuclear retinoid X receptor binding	NCOA1 NCOA6	9.16e-04	23	39	2	GO:0046965
GeneOntologyMolecularFunction	acyltransferase activity, transferring groups other than amino-acyl groups	NCOA1 NCOA3 CLOCK CREBBP	1.17e-03	238	39	4	GO:0016747
GeneOntologyMolecularFunction	nuclear thyroid hormone receptor binding	NCOA3 NCOA6	2.00e-03	34	39	2	GO:0046966
GeneOntologyMolecularFunction	disordered domain specific binding	NCOA3 CREBBP	2.63e-03	39	39	2	GO:0097718
GeneOntologyMolecularFunction	chromatin DNA binding	DDX17 CLOCK CREBBP	4.21e-03	167	39	3	GO:0031490
GeneOntologyMolecularFunction	DNA-binding transcription activator activity, RNA polymerase II-specific	NCOA3 HNF1A RUNX1 NFAT5 CLOCK	4.46e-03	560	39	5	GO:0001228
GeneOntologyMolecularFunction	DNA-binding transcription activator activity	NCOA3 HNF1A RUNX1 NFAT5 CLOCK	4.67e-03	566	39	5	GO:0001216
GeneOntologyMolecularFunction	nuclear retinoic acid receptor binding	NCOA1 NCOA6	5.17e-03	55	39	2	GO:0042974
GeneOntologyMolecularFunction	basal RNA polymerase II transcription machinery binding	NCOA3 CREBBP	7.37e-03	66	39	2	GO:0001099
GeneOntologyMolecularFunction	basal transcription machinery binding	NCOA3 CREBBP	7.37e-03	66	39	2	GO:0001098
GeneOntologyMolecularFunction	protein heterodimerization activity	HNF1A TAF4 RUNX1 SGTA	7.37e-03	398	39	4	GO:0046982
GeneOntologyMolecularFunction	protein dimerization activity	NCOA1 NCOA3 HNF1A TAF4 RUNX1 CLOCK SGTA	8.05e-03	1205	39	7	GO:0046983
GeneOntologyMolecularFunction	RNA polymerase II cis-regulatory region sequence-specific DNA binding	TARDBP HNF1A ZFHX3 CHD7 RUNX1 NFAT5 CLOCK	9.52e-03	1244	39	7	GO:0000978
GeneOntologyMolecularFunction	transcription corepressor activity	TRERF1 SSX3 CREBBP	1.00e-02	229	39	3	GO:0003714
GeneOntologyMolecularFunction	cis-regulatory region sequence-specific DNA binding	TARDBP HNF1A ZFHX3 CHD7 RUNX1 NFAT5 CLOCK	1.06e-02	1271	39	7	GO:0000987
GeneOntologyMolecularFunction	promoter-specific chromatin binding	CHD7 RUNX1	1.14e-02	83	39	2	GO:1990841
GeneOntologyMolecularFunction	histone binding	CHD7 PHC1 PYGO1	1.49e-02	265	39	3	GO:0042393
GeneOntologyMolecularFunction	acyltransferase activity	NCOA1 NCOA3 KMT2C CLOCK CREBBP	1.68e-02	775	39	5	GO:0016746
GeneOntologyBiologicalProcess	positive regulation of transcription by RNA polymerase II	TRERF1 MED12L NCOA1 NCOA3 KMT2C NCOA6 HNF1A ZFHX3 CHD7 MAML2 DDX17 TAF4 RUNX1 NFAT5 CLOCK CREBBP MAML3 PYGO1	2.01e-11	1390	40	18	GO:0045944
GeneOntologyBiologicalProcess	chromatin remodeling	NCOA1 NCOA3 KMT2C HNF1A ARID1B CHD7 NFAT5 CLOCK CREBBP PHC1	1.07e-06	741	40	10	GO:0006338
GeneOntologyBiologicalProcess	protein-DNA complex organization	NCOA1 NCOA3 KMT2C HNF1A ARID1B CHD7 TAF4 NFAT5 CLOCK CREBBP PHC1	2.06e-06	999	40	11	GO:0071824
GeneOntologyBiologicalProcess	nuclear receptor-mediated signaling pathway	TRERF1 NCOA1 NCOA3 DDX17 CLOCK MN1	2.38e-06	202	40	6	GO:0141193
GeneOntologyBiologicalProcess	chromatin organization	NCOA1 NCOA3 KMT2C HNF1A ARID1B CHD7 NFAT5 CLOCK CREBBP PHC1	5.88e-06	896	40	10	GO:0006325
GeneOntologyBiologicalProcess	hormone-mediated signaling pathway	TRERF1 NCOA1 NCOA3 DDX17 CLOCK MN1	7.06e-06	244	40	6	GO:0009755
GeneOntologyBiologicalProcess	intracellular receptor signaling pathway	TRERF1 NCOA1 NCOA3 ALPK1 DDX17 CLOCK MN1	1.35e-05	416	40	7	GO:0030522
GeneOntologyBiologicalProcess	regulation of hormone secretion	TARDBP NCOA6 HNF1A CHD7 RUNX1 CLOCK	5.84e-05	355	40	6	GO:0046883
GeneOntologyBiologicalProcess	rhythmic process	NCOA1 TARDBP ZFHX3 RUNX1 CLOCK CREBBP	6.31e-05	360	40	6	GO:0048511
GeneOntologyBiologicalProcess	positive regulation of transcription of Notch receptor target	MAML2 MAML3	7.65e-05	7	40	2	GO:0007221
GeneOntologyBiologicalProcess	in utero embryonic development	NCOA1 NCOA3 NCOA6 HNF1A CHD7 RUNX1 AMOT	1.32e-04	596	40	7	GO:0001701
GeneOntologyBiologicalProcess	nuclear receptor-mediated steroid hormone signaling pathway	TRERF1 NCOA3 DDX17 CLOCK	1.37e-04	136	40	4	GO:0030518
GeneOntologyBiologicalProcess	hormone secretion	TARDBP NCOA6 HNF1A CHD7 RUNX1 CLOCK	1.47e-04	420	40	6	GO:0046879
GeneOntologyBiologicalProcess	hormone transport	TARDBP NCOA6 HNF1A CHD7 RUNX1 CLOCK	1.71e-04	432	40	6	GO:0009914
GeneOntologyBiologicalProcess	steroid hormone receptor signaling pathway	TRERF1 NCOA3 DDX17 CLOCK	2.27e-04	155	40	4	GO:0043401
GeneOntologyBiologicalProcess	labyrinthine layer development	NCOA1 NCOA3 NCOA6	2.59e-04	64	40	3	GO:0060711
GeneOntologyBiologicalProcess	mRNA metabolic process	CSTF2 NCOA1 TARDBP DDX17 TAF4 TNRC6C AFF2 TNRC6A	3.20e-04	917	40	8	GO:0016071
GeneOntologyBiologicalProcess	nucleus organization	TARDBP AFF2 NUP155 PYGO1	3.23e-04	170	40	4	GO:0006997
GeneOntologyBiologicalProcess	positive regulation of nuclear-transcribed mRNA poly(A) tail shortening	TNRC6C TNRC6A	3.29e-04	14	40	2	GO:0060213
GeneOntologyBiologicalProcess	embryonic morphogenesis	NCOA1 NCOA3 HNF1A CHD7 TNRC6C CREBBP AMOT	3.95e-04	713	40	7	GO:0048598
GeneOntologyBiologicalProcess	regulation of nuclear-transcribed mRNA poly(A) tail shortening	TNRC6C TNRC6A	4.33e-04	16	40	2	GO:0060211
GeneOntologyBiologicalProcess	cellular response to hormone stimulus	TRERF1 NCOA1 NCOA3 ARID1B DDX17 CLOCK MN1	4.44e-04	727	40	7	GO:0032870
GeneOntologyBiologicalProcess	peptide hormone secretion	TARDBP NCOA6 HNF1A CHD7 CLOCK	4.47e-04	334	40	5	GO:0030072
GeneOntologyBiologicalProcess	peptide secretion	TARDBP NCOA6 HNF1A CHD7 CLOCK	5.04e-04	343	40	5	GO:0002790
GeneOntologyBiologicalProcess	placenta development	NCOA1 NCOA3 NCOA6 HNF1A	5.64e-04	197	40	4	GO:0001890
GeneOntologyBiologicalProcess	peptide transport	TARDBP NCOA6 HNF1A CHD7 CLOCK	5.89e-04	355	40	5	GO:0015833
GeneOntologyBiologicalProcess	embryonic organ development	NCOA1 NCOA3 NCOA6 CHD7 TNRC6C RUNX1	6.89e-04	561	40	6	GO:0048568
GeneOntologyBiologicalProcess	response to hormone	TRERF1 NCOA1 NCOA3 NCOA6 ARID1B DDX17 CLOCK MN1	7.49e-04	1042	40	8	GO:0009725
GeneOntologyBiologicalProcess	response to organic cyclic compound	TRERF1 NCOA1 NCOA3 HNF1A DDX17 CLOCK MN1 CREBBP	7.78e-04	1048	40	8	GO:0014070
GeneOntologyBiologicalProcess	response to steroid hormone	TRERF1 NCOA1 NCOA3 DDX17 CLOCK	8.10e-04	381	40	5	GO:0048545
GeneOntologyBiologicalProcess	positive regulation of ERAD pathway	HERPUD1 SGTA	8.27e-04	22	40	2	GO:1904294
GeneOntologyBiologicalProcess	reproductive structure development	NCOA1 HNF1A CHD7 TAF4 RUNX1	8.29e-04	383	40	5	GO:0048608
GeneOntologyBiologicalProcess	reproductive system development	NCOA1 HNF1A CHD7 TAF4 RUNX1	8.79e-04	388	40	5	GO:0061458
GeneOntologyBiologicalProcess	cellular response to organic cyclic compound	TRERF1 NCOA3 HNF1A DDX17 CLOCK MN1	1.02e-03	605	40	6	GO:0071407
GeneOntologyBiologicalProcess	DNA-templated transcription initiation	NCOA6 HNF1A ARID1B TAF4	1.02e-03	231	40	4	GO:0006352
GeneOntologyBiologicalProcess	cellular response to steroid hormone stimulus	TRERF1 NCOA3 DDX17 CLOCK	1.16e-03	239	40	4	GO:0071383
GeneOntologyBiologicalProcess	response to lipid	TRERF1 NCOA1 NCOA3 DDX17 RUNX1 CLOCK MN1 PHC1	1.24e-03	1126	40	8	GO:0033993
GeneOntologyBiologicalProcess	amide transport	TARDBP NCOA6 HNF1A CHD7 CLOCK	1.25e-03	420	40	5	GO:0042886
GeneOntologyBiologicalProcess	labyrinthine layer morphogenesis	NCOA1 NCOA3	1.34e-03	28	40	2	GO:0060713
GeneOntologyBiologicalProcess	embryo development	NCOA1 NCOA3 NCOA6 HNF1A CHD7 TNRC6C RUNX1 CREBBP AMOT	1.44e-03	1437	40	9	GO:0009790
GeneOntologyBiologicalProcess	regulation of ERAD pathway	HERPUD1 SGTA	1.44e-03	29	40	2	GO:1904292
GeneOntologyBiologicalProcess	signal release	TARDBP NCOA6 HNF1A CHD7 RUNX1 CLOCK	1.51e-03	653	40	6	GO:0023061
GeneOntologyBiologicalProcess	embryonic placenta development	NCOA1 NCOA3 NCOA6	1.58e-03	119	40	3	GO:0001892
GeneOntologyBiologicalProcess	chordate embryonic development	NCOA1 NCOA3 NCOA6 HNF1A CHD7 RUNX1 AMOT	1.62e-03	906	40	7	GO:0043009
GeneOntologyBiologicalProcess	cellular response to nutrient levels	NCOA1 MN1 CREBBP TNRC6A	1.62e-03	262	40	4	GO:0031669
GeneOntologyBiologicalProcess	embryonic hemopoiesis	TNRC6C RUNX1	1.75e-03	32	40	2	GO:0035162
GeneOntologyBiologicalProcess	embryo development ending in birth or egg hatching	NCOA1 NCOA3 NCOA6 HNF1A CHD7 RUNX1 AMOT	1.86e-03	929	40	7	GO:0009792
GeneOntologyBiologicalProcess	nuclear-transcribed mRNA poly(A) tail shortening	TNRC6C TNRC6A	1.86e-03	33	40	2	GO:0000289
GeneOntologyBiologicalProcess	embryonic placenta morphogenesis	NCOA1 NCOA3	1.86e-03	33	40	2	GO:0060669
GeneOntologyBiologicalProcess	regulation of hormone levels	TARDBP NCOA6 HNF1A CHD7 RUNX1 CLOCK	1.91e-03	684	40	6	GO:0010817
GeneOntologyBiologicalProcess	insulin secretion	TARDBP NCOA6 HNF1A CLOCK	1.91e-03	274	40	4	GO:0030073
GeneOntologyBiologicalProcess	regulation of miRNA-mediated gene silencing	HNF1A TNRC6C	1.98e-03	34	40	2	GO:0060964
GeneOntologyBiologicalProcess	regulation of peptide hormone secretion	TARDBP NCOA6 CHD7 CLOCK	1.99e-03	277	40	4	GO:0090276
GeneOntologyBiologicalProcess	response to retinoic acid	NCOA1 RUNX1 PHC1	2.08e-03	131	40	3	GO:0032526
GeneOntologyBiologicalProcess	regulation of peptide transport	TARDBP NCOA6 CHD7 CLOCK	2.12e-03	282	40	4	GO:0090087
GeneOntologyBiologicalProcess	regulation of peptide secretion	TARDBP NCOA6 CHD7 CLOCK	2.12e-03	282	40	4	GO:0002791
GeneOntologyBiologicalProcess	regulation of post-transcriptional gene silencing by regulatory ncRNA	HNF1A TNRC6C	2.22e-03	36	40	2	GO:1900368
GeneOntologyBiologicalProcess	developmental process involved in reproduction	NCOA1 NCOA3 HNF1A CHD7 TAF4 RUNX1 CLOCK PYGO1	2.23e-03	1235	40	8	GO:0003006
GeneOntologyBiologicalProcess	regulation of circadian rhythm	TARDBP ZFHX3 CLOCK	2.27e-03	135	40	3	GO:0042752
GeneOntologyBiologicalProcess	myoblast differentiation	ZFHX3 ARID1B DDX17	2.32e-03	136	40	3	GO:0045445
GeneOntologyBiologicalProcess	regulation of post-transcriptional gene silencing	HNF1A TNRC6C	2.34e-03	37	40	2	GO:0060147
GeneOntologyCellularComponent	nuclear protein-containing complex	TRERF1 MED12L CSTF2 NCOA1 NCOA3 KMT2C NCOA6 ARID1B TAF4 RUNX1 AFF2 NUP155 CLOCK CREBBP AMOT PHC1 BUB1B	1.56e-10	1377	40	17	GO:0140513
GeneOntologyCellularComponent	transcription regulator complex	TRERF1 NCOA1 NCOA3 NCOA6 HNF1A ZFHX3 TAF4 RUNX1 NFAT5 CLOCK CREBBP	1.01e-08	596	40	11	GO:0005667
GeneOntologyCellularComponent	chromatin	NCOA1 NCOA3 TARDBP HNF1A ZFHX3 ARID1B CHD7 TAF4 RUNX1 NFAT5 CLOCK CREBBP PHC1	2.10e-06	1480	40	13	GO:0000785
GeneOntologyCellularComponent	RNA polymerase II transcription regulator complex	NCOA1 NCOA3 TAF4 RUNX1 CLOCK CREBBP	1.22e-05	272	40	6	GO:0090575
GeneOntologyCellularComponent	nuclear body	CSTF2 TARDBP ZFHX3 MAML2 DDX17 AFF2 CREBBP MAML3 PHC1	4.11e-05	903	40	9	GO:0016604
GeneOntologyCellularComponent	perichromatin fibrils	TARDBP CLOCK	9.92e-05	8	40	2	GO:0005726
GeneOntologyCellularComponent	MLL3/4 complex	KMT2C NCOA6	2.33e-04	12	40	2	GO:0044666
GeneOntologyCellularComponent	histone methyltransferase complex	KMT2C NCOA6 TAF4	3.98e-04	75	40	3	GO:0035097
GeneOntologyCellularComponent	outer kinetochore	CREBBP BUB1B	9.59e-04	24	40	2	GO:0000940
GeneOntologyCellularComponent	methyltransferase complex	KMT2C NCOA6 TAF4	1.15e-03	108	40	3	GO:0034708
GeneOntologyCellularComponent	nuclear speck	TARDBP MAML2 DDX17 AFF2 MAML3	1.32e-03	431	40	5	GO:0016607
GeneOntologyCellularComponent	cytoplasmic ribonucleoprotein granule	TARDBP TNRC6C CLOCK TNRC6A	1.70e-03	269	40	4	GO:0036464
GeneOntologyCellularComponent	transferase complex	KMT2C NCOA6 TAF4 SOCS6 CREBBP PHC1 BUB1B	2.12e-03	963	40	7	GO:1990234
GeneOntologyCellularComponent	ribonucleoprotein granule	TARDBP TNRC6C CLOCK TNRC6A	2.16e-03	287	40	4	GO:0035770
GeneOntologyCellularComponent	nuclear ubiquitin ligase complex	PHC1 BUB1B	3.97e-03	49	40	2	GO:0000152
MousePheno	impaired hematopoiesis	RUNX1 CREBBP PHC1 TNRC6A	6.24e-06	55	31	4	MP:0001606
MousePheno	decreased hormone level	NCOA1 NCOA3 HNF1A ZFHX3 ARID1B CHD7 CLOCK CREBBP SGTA	6.38e-06	635	31	9	MP:0014455
MousePheno	decreased circulating insulin-like growth factor I level	NCOA3 HNF1A ARID1B SGTA	9.45e-06	61	31	4	MP:0004701
MousePheno	postnatal growth retardation	NCOA3 TARDBP KMT2C HNF1A ARID1B CHD7 RUNX1 NFAT5 CREBBP BUB1B	1.23e-05	881	31	10	MP:0001732
MousePheno	abnormal postnatal growth	NCOA3 TARDBP KMT2C HNF1A ARID1B CHD7 RUNX1 NFAT5 CREBBP BUB1B	1.59e-05	907	31	10	MP:0001731
MousePheno	perinatal lethality	KMT2C NCOA6 ARID1B TNRC6C RUNX1 NFAT5 MN1 CREBBP SGTA PHC1 BUB1B	1.71e-05	1130	31	11	MP:0002081
MousePheno	abnormal circulating insulin-like growth factor I level	NCOA3 HNF1A ARID1B SGTA	1.83e-05	72	31	4	MP:0004700
MousePheno	decreased circulating hormone level	NCOA1 NCOA3 HNF1A ARID1B CHD7 CLOCK CREBBP SGTA	1.96e-05	551	31	8	MP:0014457
MousePheno	abnormal insulin-like growth factor I level	NCOA3 HNF1A ARID1B SGTA	2.15e-05	75	31	4	MP:0008831
MousePheno	abnormal palatal shelf fusion at midline	NCOA6 CHD7 MN1 PHC1	2.78e-05	80	31	4	MP:0009887
MousePheno	advanced circadian behavior phase	ZFHX3 CLOCK	4.74e-05	5	31	2	MP:0020474
MousePheno	lethality during fetal growth through weaning, complete penetrance	TARDBP KMT2C NCOA6 ARID1B TNRC6C RUNX1 NFAT5 MN1 CREBBP PHC1 BUB1B	5.06e-05	1269	31	11	MP:0011111
MousePheno	abnormal pituitary hormone level	NCOA1 HNF1A ZFHX3 CHD7 CLOCK	9.86e-05	214	31	5	MP:0003965
MousePheno	abnormal hepatocyte physiology	NCOA6 HNF1A CLOCK BUB1B	1.19e-04	116	31	4	MP:0010080
MousePheno	cognitive inflexibility	TARDBP ARID1B	1.32e-04	8	31	2	MP:0014115
MousePheno	abnormal palatal shelf morphology	NCOA6 CHD7 MN1 PHC1	1.40e-04	121	31	4	MP:0031460
MousePheno	abnormal secondary palate development	NCOA6 CHD7 MN1 PHC1	1.54e-04	124	31	4	MP:0009655
MousePheno	increased circulating leptin level	NCOA1 NCOA3 CLOCK CREBBP	1.59e-04	125	31	4	MP:0005669
MousePheno	abnormal fetal cardiomyocyte proliferation	NCOA6 CHD7 NFAT5	1.60e-04	48	31	3	MP:0003567
MousePheno	prenatal lethality, incomplete penetrance	TARDBP KMT2C NCOA6 HNF1A CHD7 CREBBP AMOT TNRC6A	1.68e-04	747	31	8	MP:0011101
MousePheno	cleft secondary palate	CHD7 MN1 CREBBP PHC1	1.69e-04	127	31	4	MP:0009890
MousePheno	arrhythmic circadian behavior persistence	ZFHX3 CLOCK	1.70e-04	9	31	2	MP:0020472
MousePheno	abnormal palate development	NCOA6 CHD7 MN1 PHC1	1.80e-04	129	31	4	MP:0009653
MousePheno	abnormal circulating estradiol level	NCOA1 NCOA3 CLOCK	2.03e-04	52	31	3	MP:0005183
MousePheno	abnormal fetal cardiomyocyte physiology	NCOA6 CHD7 NFAT5	2.40e-04	55	31	3	MP:0011390
MousePheno	embryonic lethality, incomplete penetrance	KMT2C NCOA6 CHD7 CREBBP AMOT TNRC6A	2.42e-04	410	31	6	MP:0011102
MousePheno	prenatal lethality prior to heart atrial septation, incomplete penetrance	KMT2C NCOA6 CHD7 CREBBP AMOT TNRC6A	2.42e-04	410	31	6	MP:0031660
MousePheno	abnormal circadian behavior persistence	ZFHX3 CLOCK	2.59e-04	11	31	2	MP:0020471
MousePheno	abnormal circulating estrogen level	NCOA1 NCOA3 CLOCK	2.66e-04	57	31	3	MP:0003369
MousePheno	embryonic lethality during organogenesis, incomplete penetrance	NCOA6 CHD7 CREBBP AMOT TNRC6A	2.82e-04	268	31	5	MP:0011108
MousePheno	abnormal cell proliferation	NCOA3 TARDBP KMT2C NCOA6 HNF1A CHD7 TAF4 NFAT5 BUB1B TNRC6A	3.22e-04	1294	31	10	MP:0000350
MousePheno	abnormal hormone level	NCOA1 NCOA3 HNF1A ZFHX3 ARID1B CHD7 CLOCK CREBBP SGTA	3.84e-04	1073	31	9	MP:0003953
MousePheno	abnormal secondary palate morphology	CHD7 MN1 CREBBP PHC1	3.99e-04	159	31	4	MP:0013550
MousePheno	prolonged circadian behavior period	ZFHX3 CLOCK	4.26e-04	14	31	2	MP:0020469
MousePheno	abnormal pulmonary trunk morphology	CHD7 PHC1	4.26e-04	14	31	2	MP:0000486
MousePheno	abnormal myocardium compact layer morphology	NCOA6 NFAT5 CREBBP	4.30e-04	67	31	3	MP:0004056
MousePheno	abnormal hard palate morphology	CHD7 MN1 PHC1	4.30e-04	67	31	3	MP:0003756
MousePheno	increased lymphoma incidence	NCOA3 RUNX1 CREBBP BUB1B	4.49e-04	164	31	4	MP:0012431
MousePheno	abnormal hematopoietic precursor cell morphology	NCOA6 RUNX1 CREBBP PHC1 BUB1B	4.66e-04	299	31	5	MP:0013707
MousePheno	abnormal muscle morphology	NCOA3 TARDBP NCOA6 HNF1A CHD7 NFAT5 CREBBP PHC1 BUB1B	4.80e-04	1106	31	9	MP:0002108
MousePheno	dilated vasculature	NCOA6 RUNX1 AMOT	4.89e-04	70	31	3	MP:0004938
MousePheno	abnormal female reproductive system physiology	NCOA1 NCOA3 KMT2C NCOA6 CHD7 NUP155 CLOCK BUB1B	4.98e-04	876	31	8	MP:0003699
MousePheno	abnormal circulating pituitary hormone level	NCOA1 HNF1A CHD7 CLOCK	5.37e-04	172	31	4	MP:0005116
MousePheno	abnormal mouth morphology	NCOA3 NCOA6 CHD7 CLOCK MN1 CREBBP PHC1	5.40e-04	670	31	7	MP:0000452
MousePheno	absent olfactory bulb	NCOA6 CHD7	6.34e-04	17	31	2	MP:0003451
MousePheno	abnormal palate morphology	NCOA6 CHD7 MN1 CREBBP PHC1	6.44e-04	321	31	5	MP:0003755
MousePheno	increased circulating estradiol level	NCOA1 CLOCK	7.12e-04	18	31	2	MP:0005182
MousePheno	decreased fetal cardiomyocyte proliferation	NCOA6 CHD7	7.12e-04	18	31	2	MP:0011395
MousePheno	increased insulin sensitivity	NCOA3 CLOCK CREBBP BUB1B	7.50e-04	188	31	4	MP:0002891
MousePheno	perinatal lethality, complete penetrance	KMT2C ARID1B TNRC6C NFAT5 MN1 PHC1 BUB1B	7.76e-04	712	31	7	MP:0011089
MousePheno	increased circulating estrogen level	NCOA1 CLOCK	7.95e-04	19	31	2	MP:0003370
MousePheno	increased hemolymphoid system tumor incidence	NCOA3 RUNX1 CREBBP BUB1B	7.96e-04	191	31	4	MP:0010296
MousePheno	abnormal circulating hormone level	NCOA1 NCOA3 HNF1A ARID1B CHD7 CLOCK CREBBP SGTA	8.77e-04	954	31	8	MP:0005418
MousePheno	abnormal frontal lobe morphology	TARDBP CHD7	8.82e-04	20	31	2	MP:0000798
MousePheno	decreased circulating glucagon level	NCOA3 CREBBP	8.82e-04	20	31	2	MP:0002696
MousePheno	abnormal megakaryocyte morphology	RUNX1 CREBBP BUB1B	8.92e-04	86	31	3	MP:0002417
MousePheno	decreased cell proliferation	NCOA3 TARDBP KMT2C NCOA6 CHD7 NFAT5 TNRC6A	9.67e-04	739	31	7	MP:0000352
MousePheno	decreased circulating luteinizing hormone level	CHD7 CLOCK	9.74e-04	21	31	2	MP:0002773
MousePheno	digestive/alimentary phenotype	NCOA3 NCOA6 HNF1A CHD7 CLOCK MN1 CREBBP SGTA PHC1 BUB1B	1.05e-03	1500	31	10	MP:0005381
MousePheno	abnormal megakaryocyte differentiation	RUNX1 BUB1B	1.07e-03	22	31	2	MP:0000229
MousePheno	abnormal blood cell morphology/development	NCOA3 NCOA6 RUNX1 NFAT5 CREBBP PHC1 BUB1B TNRC6A	1.09e-03	986	31	8	MP:0002429
MousePheno	abnormal occipital bone morphology	MN1 CREBBP PHC1	1.19e-03	95	31	3	MP:0005269
MousePheno	stereotypic behavior	TARDBP ARID1B CHD7 CREBBP	1.21e-03	214	31	4	MP:0001408
MousePheno	muscular atrophy	TARDBP HNF1A BUB1B	1.23e-03	96	31	3	MP:0002269
MousePheno	decreased fat cell size	NCOA3 CREBBP BUB1B	1.26e-03	97	31	3	MP:0009269
MousePheno	abnormal circadian behavior phase	ZFHX3 CLOCK	1.38e-03	25	31	2	MP:0020473
MousePheno	abnormal glucose tolerance	NCOA3 CHD7 NFAT5 CLOCK CREBBP HERPUD1 BUB1B	1.40e-03	787	31	7	MP:0005291
MousePheno	decreased grip strength	MED12L TARDBP ARID1B CHD7 CREBBP BUB1B	1.44e-03	575	31	6	MP:0010053
MousePheno	abnormal circulating aspartate transaminase level	HNF1A CHD7 USP54 SGTA TMEM212	1.45e-03	385	31	5	MP:0000203
MousePheno	abnormal bone marrow hematopoietic cell morphology	RUNX1 CREBBP BUB1B	1.46e-03	102	31	3	MP:0013660
MousePheno	abnormal hypothalamus physiology	ARID1B CHD7	1.50e-03	26	31	2	MP:0005645
MousePheno	abnormal common myeloid progenitor cell morphology	RUNX1 CREBBP BUB1B	1.59e-03	105	31	3	MP:0006410
MousePheno	hyperglycemia	NCOA3 HNF1A CLOCK	1.59e-03	105	31	3	MP:0001559
MousePheno	testis hypoplasia	NCOA1 CHD7	1.61e-03	27	31	2	MP:0001940
MousePheno	premature death	NCOA3 TARDBP HNF1A ZFHX3 CHD7 AFF2 CREBBP BUB1B	1.65e-03	1051	31	8	MP:0002083
MousePheno	delayed vaginal opening	NCOA3 CHD7	1.74e-03	28	31	2	MP:0002636
MousePheno	abnormal circulating leptin level	NCOA1 NCOA3 CLOCK CREBBP	1.74e-03	236	31	4	MP:0005667
MousePheno	abnormal eating behavior	NCOA3 TARDBP HNF1A ZFHX3 CLOCK MN1	1.85e-03	604	31	6	MP:0001431
MousePheno	abnormal fat cell morphology	NCOA3 CLOCK CREBBP BUB1B	1.91e-03	242	31	4	MP:0009115
MousePheno	abnormal hematopoietic stem cell morphology	RUNX1 CREBBP PHC1	1.91e-03	112	31	3	MP:0004808
MousePheno	decreased pituitary hormone level	ZFHX3 CHD7 CLOCK	1.96e-03	113	31	3	MP:0003972
MousePheno	decreased circulating free fatty acids level	NCOA3 CHD7 CREBBP	2.11e-03	116	31	3	MP:0002702
MousePheno	abnormal blood uric acid level	HNF1A CHD7	2.13e-03	31	31	2	MP:0008820
MousePheno	abnormal timing of vaginal opening	NCOA3 CHD7	2.13e-03	31	31	2	MP:0020150
MousePheno	decreased luteinizing hormone level	CHD7 CLOCK	2.26e-03	32	31	2	MP:0005132
Domain	Nuc_rcpt_coact	NCOA1 NCOA3 CREBBP	1.81e-07	6	40	3	IPR009110
Domain	M_domain	TNRC6C TNRC6A	4.47e-06	2	40	2	PF12938
Domain	GW182_M_dom	TNRC6C TNRC6A	4.47e-06	2	40	2	IPR026805
Domain	Ago_hook	TNRC6C TNRC6A	1.34e-05	3	40	2	PF10427
Domain	Neuroggenic_mastermind-like_N	MAML2 MAML3	1.34e-05	3	40	2	IPR019082
Domain	TNRC6-PABC_bdg	TNRC6C TNRC6A	1.34e-05	3	40	2	PF16608
Domain	DUF1518	NCOA1 NCOA3	1.34e-05	3	40	2	PF07469
Domain	DUF1518	NCOA1 NCOA3	1.34e-05	3	40	2	IPR010011
Domain	Src1_rcpt_coact	NCOA1 NCOA3	1.34e-05	3	40	2	IPR008955
Domain	Nuclear_rcpt_coactivator	NCOA1 NCOA3	1.34e-05	3	40	2	IPR017426
Domain	DUF1518	NCOA1 NCOA3	1.34e-05	3	40	2	SM01151
Domain	MamL-1	MAML2 MAML3	1.34e-05	3	40	2	SM01275
Domain	Nuc_rcpt_coact_Ncoa-typ	NCOA1 NCOA3	1.34e-05	3	40	2	IPR014920
Domain	SRC-1	NCOA1 NCOA3	1.34e-05	3	40	2	IPR014935
Domain	TNRC6_PABC-bd	TNRC6C TNRC6A	1.34e-05	3	40	2	IPR032226
Domain	Argonaute_hook_dom	TNRC6C TNRC6A	1.34e-05	3	40	2	IPR019486
Domain	SRC-1	NCOA1 NCOA3	1.34e-05	3	40	2	PF08832
Domain	-	NCOA1 NCOA3	1.34e-05	3	40	2	4.10.630.10
Domain	Nuc_rec_co-act	NCOA1 NCOA3	1.34e-05	3	40	2	PF08815
Domain	MamL-1	MAML2 MAML3	1.34e-05	3	40	2	PF09596
Domain	PAS	NCOA1 NCOA3 CLOCK	2.03e-05	25	40	3	PF00989
Domain	PAS_fold	NCOA1 NCOA3 CLOCK	2.03e-05	25	40	3	IPR013767
Domain	PAS	NCOA1 NCOA3 CLOCK	4.32e-05	32	40	3	SM00091
Domain	PAS	NCOA1 NCOA3 CLOCK	5.20e-05	34	40	3	IPR000014
Domain	PAS	NCOA1 NCOA3 CLOCK	5.20e-05	34	40	3	PS50112
Domain	RRM	CSTF2 TARDBP TNRC6C TNRC6A	1.17e-03	217	40	4	SM00360
Domain	RRM_dom	CSTF2 TARDBP TNRC6C TNRC6A	1.38e-03	227	40	4	IPR000504
Domain	RRM	CSTF2 TARDBP TNRC6C TNRC6A	1.45e-03	230	40	4	PS50102
Domain	-	NCOA1 NCOA3 CLOCK	1.63e-03	109	40	3	4.10.280.10
Domain	HLH	NCOA1 NCOA3 CLOCK	1.72e-03	111	40	3	PF00010
Domain	-	CSTF2 TARDBP TNRC6C TNRC6A	1.80e-03	244	40	4	3.30.70.330
Domain	HLH	NCOA1 NCOA3 CLOCK	1.95e-03	116	40	3	SM00353
Domain	BHLH	NCOA1 NCOA3 CLOCK	2.00e-03	117	40	3	PS50888
Domain	bHLH_dom	NCOA1 NCOA3 CLOCK	2.05e-03	118	40	3	IPR011598
Domain	Nucleotide-bd_a/b_plait	CSTF2 TARDBP TNRC6C TNRC6A	2.20e-03	258	40	4	IPR012677
Pathway	REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING	MAML2 TNRC6C RUNX1 CREBBP MAML3 TNRC6A	1.98e-07	119	31	6	M607
Pathway	REACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_GENE_EXPRESSION	NCOA1 NCOA6 CLOCK CREBBP	3.24e-07	27	31	4	M26943
Pathway	REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1	KMT2C ARID1B TNRC6C RUNX1 CREBBP PHC1 TNRC6A	6.48e-07	237	31	7	M27786
Pathway	REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION	NCOA1 NCOA3 TNRC6C RUNX1 CREBBP TNRC6A	7.46e-07	149	31	6	M27888
Pathway	REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3	ZFHX3 MAML2 RUNX1 CREBBP MAML3	1.95e-06	96	31	5	M27784
Pathway	REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT	HNF1A MAML2 CREBBP MAML3	2.02e-06	42	31	4	M17541
Pathway	REACTOME_SUMOYLATION_OF_TRANSCRIPTION_COFACTORS	NCOA1 DDX17 CREBBP PHC1	2.44e-06	44	31	4	M27295
Pathway	REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING	MAML2 CREBBP MAML3	3.45e-06	14	31	3	M27808
Pathway	REACTOME_HEME_SIGNALING	NCOA1 NCOA6 CLOCK CREBBP	3.78e-06	49	31	4	M41832
Pathway	WP_RUBINSTEINTAYBI_SYNDROME_1	NCOA3 CLOCK CREBBP	4.30e-06	15	31	3	M48323
Pathway	REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_LATE_STAGE_BRANCHING_MORPHOGENESIS_PANCREATIC_BUD_PRECURSOR_CELLS	MAML2 CREBBP MAML3	5.29e-06	16	31	3	M27121
Pathway	REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA	NCOA1 NCOA3 NCOA6 CLOCK CREBBP	5.39e-06	118	31	5	M27316
Pathway	REACTOME_REGULATION_OF_RUNX1_EXPRESSION_AND_ACTIVITY	TNRC6C RUNX1 TNRC6A	6.41e-06	17	31	3	M27788
Pathway	REACTOME_ESR_MEDIATED_SIGNALING	NCOA1 NCOA3 TNRC6C RUNX1 CREBBP TNRC6A	7.17e-06	220	31	6	M27794
Pathway	REACTOME_RORA_ACTIVATES_GENE_EXPRESSION	NCOA1 NCOA6 CREBBP	7.68e-06	18	31	3	M26942
Pathway	REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION	MAML2 CREBBP MAML3	1.07e-05	20	31	3	M27881
Pathway	REACTOME_SIGNALING_BY_NOTCH	MAML2 TNRC6C RUNX1 CREBBP MAML3 TNRC6A	1.36e-05	246	31	6	M10189
Pathway	REACTOME_CIRCADIAN_CLOCK	NCOA1 NCOA6 CLOCK CREBBP	1.59e-05	70	31	4	M938
Pathway	REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION	CSTF2 KMT2C ZFHX3 ARID1B MAML2 TAF4 TNRC6C RUNX1 CREBBP MAML3 PHC1 TNRC6A	1.87e-05	1387	31	12	M734
Pathway	REACTOME_NOTCH3_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION	MAML2 CREBBP MAML3	2.14e-05	25	31	3	M27880
Pathway	REACTOME_DEVELOPMENTAL_BIOLOGY	NCOA1 NCOA3 KMT2C NCOA6 HNF1A ARID1B MAML2 TNRC6C RUNX1 CREBBP MAML3 TNRC6A	2.58e-05	1432	31	12	M509
Pathway	REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY	MAML2 CREBBP MAML3	3.04e-05	28	31	3	M6177
Pathway	REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION	NCOA1 NCOA3 NCOA6 CREBBP	3.26e-05	84	31	4	M1008
Pathway	WP_KLEEFSTRA_SYNDROME	KMT2C NCOA6 ARID1B	3.38e-05	29	31	3	M48076
Pathway	PID_RETINOIC_ACID_PATHWAY	NCOA1 NCOA3 CREBBP	3.76e-05	30	31	3	M207
Pathway	REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS	NCOA1 NCOA3 TNRC6C RUNX1 CREBBP TNRC6A	3.85e-05	296	31	6	M27869
Pathway	REACTOME_REGULATION_OF_HOMOTYPIC_CELL_CELL_ADHESION	TNRC6C AMOT TNRC6A	4.57e-05	32	31	3	M48012
Pathway	KEGG_MEDICUS_VARIANT_ESR1_POSITIVE_TO_NUCLEAR_INITIATED_ESTROGEN_SIGNALING_PATHWAY	NCOA1 NCOA3	4.66e-05	5	31	2	M48983
Pathway	REACTOME_CELLULAR_RESPONSES_TO_STIMULI	NCOA1 NCOA6 TNRC6C NUP155 CLOCK CREBBP HERPUD1 PHC1 TNRC6A	4.97e-05	828	31	9	M27827
Pathway	REACTOME_SUMOYLATION	NCOA1 DDX17 NUP155 CREBBP PHC1	5.26e-05	189	31	5	M27214
Pathway	REACTOME_TRANSCRIPTIONAL_REGULATION_BY_NPAS4	TNRC6C CREBBP TNRC6A	5.50e-05	34	31	3	M46422
Pathway	REACTOME_RUNX1_REGULATES_GENES_INVOLVED_IN_MEGAKARYOCYTE_DIFFERENTIATION_AND_PLATELET_FUNCTION	KMT2C TNRC6C RUNX1 TNRC6A	5.52e-05	96	31	4	M27792
Pathway	REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN	ARID1B RUNX1 PHC1	7.11e-05	37	31	3	M27797
Pathway	REACTOME_NR1H3_NR1H2_REGULATE_GENE_EXPRESSION_LINKED_TO_CHOLESTEROL_TRANSPORT_AND_EFFLUX	NCOA1 TNRC6C TNRC6A	7.11e-05	37	31	3	M29790
Pathway	REACTOME_SUMOYLATION_OF_TRANSCRIPTION_COFACTORS	NCOA1 DDX17 PHC1	9.00e-05	40	31	3	MM15000
Pathway	REACTOME_ADIPOGENESIS	NCOA1 NCOA3 NCOA6 CREBBP	9.39e-05	110	31	4	M48259
Pathway	REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_DIFFERENTIATION_OF_MYELOID_CELLS	RUNX1 CREBBP	9.76e-05	7	31	2	M27799
Pathway	REACTOME_POST_TRANSCRIPTIONAL_SILENCING_BY_SMALL_RNAS	TNRC6C TNRC6A	9.76e-05	7	31	2	M46421
Pathway	REACTOME_ACTIVATION_OF_GENE_EXPRESSION_BY_SREBF_SREBP	NCOA1 NCOA6 CREBBP	1.04e-04	42	31	3	M27172
Pathway	BIOCARTA_PPARG_PATHWAY	NCOA1 CREBBP	1.30e-04	8	31	2	M22058
Pathway	REACTOME_ACTIVATION_OF_ANTERIOR_HOX_GENES_IN_HINDBRAIN_DEVELOPMENT_DURING_EARLY_EMBRYOGENESIS	NCOA3 KMT2C NCOA6 CREBBP	1.40e-04	122	31	4	M29689
Pathway	KEGG_NOTCH_SIGNALING_PATHWAY	MAML2 CREBBP MAML3	1.46e-04	47	31	3	M7946
Pathway	REACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING	NCOA1 TNRC6C TNRC6A	1.46e-04	47	31	3	M29777
Pathway	PID_HES_HEY_PATHWAY	NCOA1 MAML2 CREBBP	1.56e-04	48	31	3	M288
Pathway	REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION	MAML2 CREBBP MAML3	1.56e-04	48	31	3	M611
Pathway	REACTOME_SIGNALING_BY_NOTCH3	MAML2 CREBBP MAML3	1.66e-04	49	31	3	M618
Pathway	REACTOME_REGULATION_OF_PTEN_MRNA_TRANSLATION	TNRC6C TNRC6A	1.67e-04	9	31	2	M27810
Pathway	REACTOME_REGULATION_OF_NPAS4_MRNA_TRANSLATION	TNRC6C TNRC6A	1.67e-04	9	31	2	M46436
Pathway	REACTOME_REGULATION_OF_CDH11_MRNA_TRANSLATION_BY_MICRORNAS	TNRC6C TNRC6A	2.08e-04	10	31	2	M48013
Pathway	REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING	MAML2 MAML3	2.08e-04	10	31	2	MM15535
Pathway	REACTOME_MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT	ARID1B TNRC6C CREBBP TNRC6A	2.19e-04	137	31	4	M48232
Pathway	REACTOME_TRANSCRIPTIONAL_ACTIVATION_OF_MITOCHONDRIAL_BIOGENESIS	NCOA1 NCOA6 CREBBP	2.34e-04	55	31	3	M27145
Pathway	REACTOME_REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF	NCOA1 NCOA6 CREBBP	2.34e-04	55	31	3	M27001
Pathway	KEGG_MEDICUS_REFERENCE_NUCLEAR_INITIATED_ESTROGEN_SIGNALING_PATHWAY	NCOA1 NCOA3	2.54e-04	11	31	2	M47503
Pathway	REACTOME_SIGNALING_BY_NOTCH1_PEST_DOMAIN_MUTANTS_IN_CANCER	MAML2 CREBBP MAML3	2.74e-04	58	31	3	M29616
Pathway	REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS	TNRC6C AMOT TNRC6A	2.74e-04	58	31	3	M11980
Pathway	REACTOME_CHROMATIN_MODIFYING_ENZYMES	NCOA1 KMT2C ARID1B CLOCK CREBBP	2.90e-04	272	31	5	M29619
Pathway	REACTOME_CYTOPROTECTION_BY_HMOX1	NCOA1 NCOA6 CREBBP	3.03e-04	60	31	3	M41830
Pathway	REACTOME_NOTCH2_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION	MAML2 MAML3	3.05e-04	12	31	2	M27159
Pathway	KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00380	MAML2 MAML3	3.05e-04	12	31	2	M47532
Pathway	KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00381	MAML2 MAML3	3.05e-04	12	31	2	M47533
Pathway	KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00382	MAML2 MAML3	3.60e-04	13	31	2	M47534
Pathway	REACTOME_REGULATION_OF_NPAS4_GENE_EXPRESSION	TNRC6C TNRC6A	3.60e-04	13	31	2	M46434
Pathway	PID_ERA_GENOMIC_PATHWAY	NCOA1 NCOA3 DDX17	3.66e-04	64	31	3	M200
Pathway	WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA	KMT2C CREBBP MAML3	3.84e-04	65	31	3	M39682
Pathway	REACTOME_FORMATION_OF_PARAXIAL_MESODERM	MAML2 CREBBP MAML3	4.57e-04	69	31	3	M46439
Pathway	PID_ERB_GENOMIC_PATHWAY	NCOA1 NCOA3	4.83e-04	15	31	2	M119
Pathway	REACTOME_SUMOYLATION	NCOA1 DDX17 NUP155 PHC1	4.87e-04	169	31	4	MM14919
Pathway	REACTOME_SIGNALING_BY_NOTCH1	MAML2 CREBBP MAML3	5.62e-04	74	31	3	M616
Pathway	REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3	ZFHX3 MAML2 MAML3	6.07e-04	76	31	3	MM15520
Pathway	REACTOME_SIGNALING_BY_NOTCH1	MAML2 MAML3	7.01e-04	18	31	2	MM14775
Pathway	REACTOME_SIGNALING_BY_NOTCH4	MAML2 CREBBP MAML3	7.58e-04	82	31	3	M594
Pathway	PID_SMAD2_3NUCLEAR_PATHWAY	NCOA1 RUNX1 CREBBP	7.58e-04	82	31	3	M2
Pathway	REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_APOPTOSIS	TNRC6C TNRC6A	7.82e-04	19	31	2	M48238
Pathway	REACTOME_CELL_CELL_JUNCTION_ORGANIZATION	TNRC6C AMOT TNRC6A	9.94e-04	90	31	3	M820
Pathway	WP_ANDROGEN_RECEPTOR_SIGNALING	NCOA1 NCOA3 CREBBP	1.03e-03	91	31	3	M39700
Pathway	BIOCARTA_VDR_PATHWAY	NCOA3 CREBBP	1.05e-03	22	31	2	MM1370
Pathway	REACTOME_MAPK6_MAPK4_SIGNALING	NCOA3 TNRC6C TNRC6A	1.09e-03	93	31	3	M27572
Pathway	BIOCARTA_WNT_PATHWAY	HNF1A CREBBP	1.15e-03	23	31	2	MM1527
Pathway	REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY	MAML2 MAML3	1.15e-03	23	31	2	MM14954
Pathway	REACTOME_MITF_M_DEPENDENT_GENE_EXPRESSION	ARID1B TNRC6C TNRC6A	1.16e-03	95	31	3	M48268
Pathway	REACTOME_MITOCHONDRIAL_BIOGENESIS	NCOA1 NCOA6 CREBBP	1.20e-03	96	31	3	M26973
Pathway	BIOCARTA_WNT_PATHWAY	HNF1A CREBBP	1.25e-03	24	31	2	M16517
Pathway	BIOCARTA_VDR_PATHWAY	NCOA1 CREBBP	1.25e-03	24	31	2	M13404
Pathway	REACTOME_GENE_EXPRESSION_TRANSCRIPTION	CSTF2 ZFHX3 MAML2 TAF4 NUP155 MAML3 PHC1 TNRC6A	1.30e-03	1022	31	8	MM15436
Pathway	WP_IL6_SIGNALING_PATHWAY	NCOA1 HNF1A CREBBP	1.35e-03	100	31	3	MM15826
Pathway	WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING	MAML2 MAML3	1.59e-03	27	31	2	M39545
Pathway	REACTOME_TGFBR3_EXPRESSION	TNRC6C TNRC6A	1.71e-03	28	31	2	M48253
Pathway	WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY	NCOA1 NCOA6	2.09e-03	31	31	2	M39476
Pathway	REACTOME_CELL_JUNCTION_ORGANIZATION	TNRC6C AMOT TNRC6A	2.11e-03	117	31	3	M19248
Pathway	WP_PREGNANE_X_RECEPTOR_PATHWAY	NCOA1 NCOA3	2.23e-03	32	31	2	M39567
Pathway	REACTOME_REGULATION_OF_MECP2_EXPRESSION_AND_ACTIVITY	TNRC6C TNRC6A	2.23e-03	32	31	2	M27900
Pathway	REACTOME_SIGNALING_BY_NOTCH2	MAML2 MAML3	2.37e-03	33	31	2	M604
Pathway	REACTOME_OXIDATIVE_STRESS_INDUCED_SENESCENCE	TNRC6C PHC1 TNRC6A	2.55e-03	125	31	3	M27186
Pathway	REACTOME_ONCOGENE_INDUCED_SENESCENCE	TNRC6C TNRC6A	2.66e-03	35	31	2	M27190
Pathway	REACTOME_GASTRULATION	MAML2 CREBBP MAML3	2.79e-03	129	31	3	M46433
Pathway	REACTOME_SIGNALING_BY_NOTCH	MAML2 MAML3	3.30e-03	39	31	2	MM14604
Pathway	REACTOME_PTEN_REGULATION	TNRC6C PHC1 TNRC6A	3.45e-03	139	31	3	M27646
Pathway	REACTOME_GENE_SILENCING_BY_RNA	TNRC6C NUP155 TNRC6A	3.45e-03	139	31	3	M715
Pathway	REACTOME_TRANSCRIPTIONAL_REGULATION_BY_VENTX	TNRC6C TNRC6A	3.64e-03	41	31	2	M29748
Pubmed	Human transcription factor protein interaction networks.	TRERF1 CSTF2 NCOA1 NCOA3 TARDBP KMT2C NCOA6 HNF1A ZFHX3 ARID1B CHD7 USP54 TAF4 TNRC6C USP27X CREBBP PYGO1 TNRC6A	4.81e-15	1429	40	18	35140242
Pubmed	Interaction network of human early embryonic transcription factors.	TRERF1 NCOA1 NCOA3 KMT2C NCOA6 ZFHX3 ARID1B CHD7 TAF4 CREBBP	6.25e-12	351	40	10	38297188
Pubmed	Transcriptional activation by hepatocyte nuclear factor-1 requires synergism between multiple coactivator proteins.	NCOA1 NCOA3 HNF1A CREBBP	2.25e-11	6	40	4	10777539
Pubmed	Activating signal cointegrator 2 belongs to a novel steady-state complex that contains a subset of trithorax group proteins.	NCOA1 KMT2C NCOA6 CREBBP	1.49e-09	14	40	4	12482968
Pubmed	Steroid receptor coactivator-1 and its family members differentially regulate transactivation by the tumor suppressor protein p53.	NCOA1 NCOA3 CREBBP	5.63e-09	4	40	3	10551785
Pubmed	Mutation of a lysine residue in a homeodomain generates dominant negative thyroid transcription factor 1.	NCOA1 NCOA3 CREBBP	5.63e-09	4	40	3	15449938
Pubmed	TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation.	NCOA1 NCOA3 TARDBP KMT2C ZFHX3 ARID1B DDX17	5.75e-09	220	40	7	35785414
Pubmed	New nomenclature for chromatin-modifying enzymes.	NCOA1 NCOA3 KMT2C CLOCK CREBBP	6.22e-09	57	40	5	18022353
Pubmed	T0070907, a selective ligand for peroxisome proliferator-activated receptor gamma, functions as an antagonist of biochemical and cellular activities.	NCOA1 NCOA3 NCOA6 CREBBP	7.17e-09	20	40	4	11877444
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	MED12L KMT2C NCOA6 ARID1B MAML2 NUP155 CLOCK AMOT TNRC6A	7.32e-09	529	40	9	14621295
Pubmed	Nuclear receptor-coregulator interaction profiling identifies TRIP3 as a novel peroxisome proliferator-activated receptor gamma cofactor.	NCOA1 NCOA3 NCOA6 CREBBP	8.85e-09	21	40	4	19596656
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	CSTF2 TARDBP KMT2C NCOA6 ARID1B TAF4 CREBBP AMOT BUB1B	1.01e-08	549	40	9	38280479
Pubmed	Transcription factor-specific requirements for coactivators and their acetyltransferase functions.	NCOA1 NCOA3 CREBBP	1.41e-08	5	40	3	9445475
Pubmed	Lysine 246 of the vitamin D receptor is crucial for ligand-dependent interaction with coactivators and transcriptional activity.	NCOA1 NCOA3 CREBBP	1.41e-08	5	40	3	10224118
Pubmed	The Eyes Absent family members EYA4 and EYA1 promote PLK1 activation and successful mitosis through tyrosine dephosphorylation.	NCOA1 NCOA3 TNRC6C CREBBP AMOT TNRC6A	2.14e-08	152	40	6	38360978
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	TRERF1 NCOA3 ZFHX3 CHD7 AMOT PHC1 BUB1B TNRC6A	2.24e-08	418	40	8	34709266
Pubmed	Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.	TRERF1 NCOA1 NCOA3 NCOA6 ARID1B CHD7 CREBBP	2.24e-08	268	40	7	33640491
Pubmed	Temporal/spatial expression of nuclear receptor coactivators in the mouse lung.	NCOA1 NCOA3 CREBBP	2.81e-08	6	40	3	11076796
Pubmed	Agonist-specific Protein Interactomes of Glucocorticoid and Androgen Receptor as Revealed by Proximity Mapping.	NCOA1 NCOA3 NCOA6 ARID1B CHD7	3.08e-08	78	40	5	28611094
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	TRERF1 NCOA1 NCOA3 KMT2C NCOA6 ARID1B CHD7 DDX17 TAF4 RUNX1 CREBBP	3.09e-08	1103	40	11	34189442
Pubmed	Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation.	NCOA3 KMT2C NCOA6 ARID1B NUP155 CREBBP MAML3 TNRC6A	4.45e-08	457	40	8	32344865
Pubmed	BRCA1-IRIS regulates cyclin D1 expression in breast cancer cells.	NCOA1 NCOA3 CREBBP	4.92e-08	7	40	3	16860316
Pubmed	The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function.	NCOA1 NCOA3 CREBBP	4.92e-08	7	40	3	9192892
Pubmed	Regulation of SRC-3 (pCIP/ACTR/AIB-1/RAC-3/TRAM-1) Coactivator activity by I kappa B kinase.	NCOA1 NCOA3 CREBBP	7.86e-08	8	40	3	11971985
Pubmed	A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors.	NCOA1 NCOA3 CREBBP	7.86e-08	8	40	3	8616895
Pubmed	Aberrant association of promyelocytic leukemia protein-retinoic acid receptor-alpha with coactivators contributes to its ability to regulate gene expression.	NCOA1 NCOA3 CREBBP	7.86e-08	8	40	3	17475621
Pubmed	A genome-wide screen to identify transcription factors expressed in pelvic Ganglia of the lower urinary tract.	NCOA1 KMT2C HNF1A ZFHX3 NFAT5 CREBBP MAML3 PHC1 PYGO1	8.99e-08	709	40	9	22988430
Pubmed	TRAM-1, A novel 160-kDa thyroid hormone receptor activator molecule, exhibits distinct properties from steroid receptor coactivator-1.	NCOA1 NCOA3 CREBBP	1.18e-07	9	40	3	9346901
Pubmed	Genome-wide interrogation of germline genetic variation associated with treatment response in childhood acute lymphoblastic leukemia.	NCOA3 ARID1B MAML2	1.18e-07	9	40	3	19176441
Pubmed	Hematopoiesis controlled by distinct TIF1gamma and Smad4 branches of the TGFbeta pathway.	NCOA3 ARID1B CREBBP	1.68e-07	10	40	3	16751102
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	KMT2C NCOA6 CHD7 ALPK1 TNRC6C AMOT	2.19e-07	225	40	6	12168954
Pubmed	The Hippocampal Response to Acute Corticosterone Elevation Is Altered in a Mouse Model for Angelman Syndrome.	NCOA1 NCOA3 NCOA6	2.31e-07	11	40	3	36613751
Pubmed	The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation.	TARDBP ZFHX3 CHD7 DDX17 TAF4 RUNX1 NUP155 NFAT5	2.85e-07	583	40	8	29844126
Pubmed	Identification of a transcriptionally active peroxisome proliferator-activated receptor alpha -interacting cofactor complex in rat liver and characterization of PRIC285 as a coactivator.	NCOA1 NCOA6 CREBBP	3.08e-07	12	40	3	12189208
Pubmed	Histone acetyltransferase-dependent chromatin remodeling and the vascular clock.	NCOA3 CLOCK CREBBP	3.08e-07	12	40	3	14645221
Pubmed	Identification and functional characterization of transcriptional activators in human cells.	NCOA1 NCOA3 KMT2C ARID1B CHD7 USP54 CREBBP	3.28e-07	398	40	7	35016035
Pubmed	Regulation of glucocorticoid receptor activity by 14--3-3-dependent intracellular relocalization of the corepressor RIP140.	NCOA1 NCOA3 CREBBP	4.00e-07	13	40	3	11266503
Pubmed	E protein silencing by the leukemogenic AML1-ETO fusion protein.	TAF4 RUNX1 CREBBP	5.08e-07	14	40	3	15333839
Pubmed	Proteomic Analysis of the EWS-Fli-1 Interactome Reveals the Role of the Lysosome in EWS-Fli-1 Turnover.	CSTF2 NCOA3 NCOA6 DDX17 TAF4 CREBBP AMOT	5.10e-07	425	40	7	24999758
Pubmed	A nuclear factor, ASC-2, as a cancer-amplified transcriptional coactivator essential for ligand-dependent transactivation by nuclear receptors in vivo.	NCOA1 NCOA6 CREBBP	6.35e-07	15	40	3	10567404
Pubmed	Screening and association testing of common coding variation in steroid hormone receptor co-activator and co-repressor genes in relation to breast cancer risk: the Multiethnic Cohort.	NCOA1 NCOA3 CREBBP	9.48e-07	17	40	3	19183483
Pubmed	The Epigenetic Factor Landscape of Developing Neocortex Is Regulated by Transcription Factors Pax6→ Tbr2→ Tbr1.	NCOA6 ARID1B CHD7 CREBBP PHC1	1.02e-06	157	40	5	30186101
Pubmed	T-cell receptor signaling induces proximal Runx1 transactivation via a calcineurin-NFAT pathway.	RUNX1 NFAT5	1.29e-06	2	40	2	24310293
Pubmed	Quantifying Protection in Disordered Proteins Using Millisecond Hydrogen Exchange-Mass Spectrometry and Peptic Reference Peptides.	NCOA3 CREBBP	1.29e-06	2	40	2	28675294
Pubmed	The coactivator SRC-1 is an essential coordinator of hepatic glucose production.	NCOA1 NCOA3	1.29e-06	2	40	2	21109193
Pubmed	Steroid receptor coactivator (SRC)-1 and SRC-3 differentially modulate tissue-specific activation functions of the progesterone receptor.	NCOA1 NCOA3	1.29e-06	2	40	2	16141356
Pubmed	Immunohistochemical localization of steroid receptor coactivators in chondrosarcoma: an in vivo tissue microarray study.	NCOA1 NCOA3	1.29e-06	2	40	2	24875297
Pubmed	Methylation specifies distinct estrogen-induced binding site repertoires of CBP to chromatin.	NCOA3 CREBBP	1.29e-06	2	40	2	21632823
Pubmed	Critical roles of the p160 transcriptional coactivators p/CIP and SRC-1 in energy balance.	NCOA1 NCOA3	1.29e-06	2	40	2	16459312
Pubmed	The NCOA1-CBP-NF-κB transcriptional complex induces inflammation response and triggers endotoxin-induced myocardial dysfunction.	NCOA1 CREBBP	1.29e-06	2	40	2	35339471
Pubmed	Hybrid selection of transcribed sequences from microdissected DNA: isolation of genes within amplified region at 20q11-q13.2 in breast cancer.	NCOA3 NCOA6	1.29e-06	2	40	2	8758910
Pubmed	Early embryonic lethality of mice with disrupted transcription cofactor PIMT/NCOA6IP/Tgs1 gene.	NCOA1 NCOA6 CREBBP	1.35e-06	19	40	3	22982455
Pubmed	ARIH2 Is a Vif-Dependent Regulator of CUL5-Mediated APOBEC3G Degradation in HIV Infection.	DDX17 TAF4 TNRC6C SOCS6 RUNX1 TNRC6A	2.26e-06	336	40	6	31253590
Pubmed	cDNAs with long CAG trinucleotide repeats from human brain.	NCOA3 MAML3 TNRC6A	2.46e-06	23	40	3	9225980
Pubmed	Identification of the SOX2 Interactome by BioID Reveals EP300 as a Mediator of SOX2-dependent Squamous Differentiation and Lung Squamous Cell Carcinoma Growth.	NCOA3 NCOA6 ARID1B CHD7	2.58e-06	83	40	4	28794006
Pubmed	Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.	TRERF1 NCOA1 NCOA3 HNF1A ZFHX3 NFAT5 CLOCK PHC1	3.27e-06	808	40	8	20412781
Pubmed	Identification of new human mastermind proteins defines a family that consists of positive regulators for notch signaling.	MAML2 MAML3	3.87e-06	3	40	2	12386158
Pubmed	MN1-TEL myeloid oncoprotein expressed in multipotent progenitors perturbs both myeloid and lymphoid growth and causes T-lymphoid tumors in mice.	RUNX1 MN1	3.87e-06	3	40	2	16081688
Pubmed	Coactivator ASC-2 mediates heat shock factor 1-mediated transactivation dependent on heat shock.	NCOA6 CREBBP	3.87e-06	3	40	2	14960326
Pubmed	The transcriptional coregulators TIF2 and SRC-1 regulate energy homeostasis by modulating mitochondrial respiration in skeletal muscles.	NCOA1 NCOA3	3.87e-06	3	40	2	21035760
Pubmed	Distinctive functions of p160 steroid receptor coactivators in proliferation of an estrogen-independent, tamoxifen-resistant breast cancer cell line.	NCOA1 NCOA3	3.87e-06	3	40	2	21059860
Pubmed	Ligand-independent recruitment of steroid receptor coactivators to estrogen receptor by cyclin D1.	NCOA1 NCOA3	3.87e-06	3	40	2	9832502
Pubmed	Absence of the steroid receptor coactivator-3 induces B-cell lymphoma.	NCOA1 NCOA3	3.87e-06	3	40	2	16675958
Pubmed	Partial hormone resistance in mice with disruption of the steroid receptor coactivator-1 (SRC-1) gene.	NCOA1 NCOA3	3.87e-06	3	40	2	9506940
Pubmed	Steroid receptor coactivators present a unique opportunity for drug development in hormone-dependent cancers.	NCOA1 NCOA3	3.87e-06	3	40	2	28390937
Pubmed	A mutant form of ERα associated with estrogen insensitivity affects the coupling between ligand binding and coactivator recruitment.	NCOA1 NCOA3	3.87e-06	3	40	2	32963012
Pubmed	Research resource: loss of the steroid receptor coactivators confers neurobehavioral consequences.	NCOA1 NCOA3	3.87e-06	3	40	2	23927929
Pubmed	The MN1 oncoprotein synergizes with coactivators RAC3 and p300 in RAR-RXR-mediated transcription.	NCOA3 MN1	3.87e-06	3	40	2	12569362
Pubmed	Peroxisome proliferator-activated receptor gamma-dependent repression of the inducible nitric oxide synthase gene.	NCOA1 CREBBP	3.87e-06	3	40	2	10848596
Pubmed	Transcriptional coactivators CBP and p300 cooperatively enhance HNF-1alpha-mediated expression of the albumin gene in hepatocytes.	HNF1A CREBBP	3.87e-06	3	40	2	15598887
Pubmed	Activating signal cointegrator-2 is an essential adaptor to recruit histone H3 lysine 4 methyltransferases MLL3 and MLL4 to the liver X receptors.	KMT2C NCOA6	3.87e-06	3	40	2	18372346
Pubmed	Histone H3K4 trimethylation by MLL3 as part of ASCOM complex is critical for NR activation of bile acid transporter genes and is downregulated in cholestasis.	KMT2C NCOA6	3.87e-06	3	40	2	21330447
Pubmed	Glutamine rich and basic region/leucine zipper (bZIP) domains stabilize cAMP-response element-binding protein (CREB) binding to chromatin.	TAF4 CREBBP	3.87e-06	3	40	2	15703171
Pubmed	Role of CBP/p300 and SRC-1 in transcriptional regulation of the pulmonary surfactant protein-A (SP-A) gene by thyroid transcription factor-1 (TTF-1).	NCOA1 CREBBP	3.87e-06	3	40	2	11713256
Pubmed	Mutual synergistic folding in recruitment of CBP/p300 by p160 nuclear receptor coactivators.	NCOA3 CREBBP	3.87e-06	3	40	2	11823864
Pubmed	Dual role of the ddx5/ddx17 RNA helicases in the control of the pro-migratory NFAT5 transcription factor.	DDX17 NFAT5	3.87e-06	3	40	2	22266867
Pubmed	Expression and significance of androgen receptor coactivators in urothelial carcinoma of the bladder.	NCOA1 NCOA3	3.87e-06	3	40	2	18845648
Pubmed	Impact of scaffolding protein TNRC6 paralogs on gene expression and splicing.	TNRC6C TNRC6A	3.87e-06	3	40	2	34108231
Pubmed	The function of TIF2/GRIP1 in mouse reproduction is distinct from those of SRC-1 and p/CIP.	NCOA1 NCOA3	3.87e-06	3	40	2	12138202
Pubmed	t(11;19)(q21;p13) translocation in mucoepidermoid carcinoma creates a novel fusion product that disrupts a Notch signaling pathway.	MAML2 MAML3	3.87e-06	3	40	2	12539049
Pubmed	A novel zinc finger protein TReP-132 interacts with CBP/p300 to regulate human CYP11A1 gene expression.	TRERF1 CREBBP	3.87e-06	3	40	2	11349124
Pubmed	Structure and chromosomal locations of mouse steroid receptor coactivator gene family.	NCOA1 NCOA3	3.87e-06	3	40	2	10501088
Pubmed	Estradiol increases cell growth in human astrocytoma cell lines through ERα activation and its interaction with SRC-1 and SRC-3 coactivators.	NCOA1 NCOA3	3.87e-06	3	40	2	22142990
Pubmed	Gawky is a component of cytoplasmic mRNA processing bodies required for early Drosophila development.	TNRC6C TNRC6A	3.87e-06	3	40	2	16880270
Pubmed	The transcriptional coactivators p/CIP and SRC-1 control insulin resistance through IRS1 in obesity models.	NCOA1 NCOA3	3.87e-06	3	40	2	22859932
Pubmed	The steroid receptor coactivator-1 regulates twist expression and promotes breast cancer metastasis.	NCOA1 NCOA3	3.87e-06	3	40	2	19383905
Pubmed	Transcriptional activation by STAT6 requires the direct interaction with NCoA-1.	NCOA1 CREBBP	3.87e-06	3	40	2	11574547
Pubmed	Expression of TNRC6 (GW182) Proteins Is Not Necessary for Gene Silencing by Fully Complementary RNA Duplexes.	TNRC6C TNRC6A	3.87e-06	3	40	2	31670606
Pubmed	The genomic analysis of the impact of steroid receptor coactivators ablation on hepatic metabolism.	NCOA1 NCOA3	3.87e-06	3	40	2	16423883
Pubmed	Increased gene copy number of VAMP7 disrupts human male urogenital development through altered estrogen action.	NCOA1 NCOA3 CREBBP	4.53e-06	28	40	3	24880616
Pubmed	An atlas of combinatorial transcriptional regulation in mouse and man.	NCOA3 TARDBP HNF1A SSX3 CLOCK CREBBP MAML3 PYGO1	5.96e-06	877	40	8	20211142
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	NCOA1 NCOA3 NCOA6 ARID1B CHD7 CREBBP MAML3	7.46e-06	638	40	7	31182584
Pubmed	A census of human transcription factors: function, expression and evolution.	TRERF1 NCOA1 NCOA3 HNF1A ZFHX3 RUNX1 NFAT5 CLOCK	7.67e-06	908	40	8	19274049
Pubmed	miR-137 Targets p160 Steroid Receptor Coactivators SRC1, SRC2, and SRC3 and Inhibits Cell Proliferation.	NCOA1 NCOA3	7.73e-06	4	40	2	26066330
Pubmed	Peptidyl-prolyl isomerase 1 (Pin1) serves as a coactivator of steroid receptor by regulating the activity of phosphorylated steroid receptor coactivator 3 (SRC-3/AIB1).	NCOA3 CREBBP	7.73e-06	4	40	2	16227615
Pubmed	Sumoylation controls CLOCK-BMAL1-mediated clock resetting via CBP recruitment in nuclear transcriptional foci.	CLOCK CREBBP	7.73e-06	4	40	2	26164627
Pubmed	Targeting NSD2-mediated SRC-3 liquid-liquid phase separation sensitizes bortezomib treatment in multiple myeloma.	NCOA3 CREBBP	7.73e-06	4	40	2	33589584
Pubmed	CBP/p300 is a cell type-specific modulator of CLOCK/BMAL1-mediated transcription.	CLOCK CREBBP	7.73e-06	4	40	2	19922678
Pubmed	MLL3/MLL4 are required for CBP/p300 binding on enhancers and super-enhancer formation in brown adipogenesis.	KMT2C CREBBP	7.73e-06	4	40	2	28398509
Pubmed	A signature motif in transcriptional co-activators mediates binding to nuclear receptors.	NCOA1 CREBBP	7.73e-06	4	40	2	9192902
Interaction	TLE3 interactions	TRERF1 CSTF2 NCOA1 NCOA3 ZFHX3 ARID1B DDX17 TAF4 RUNX1 CLOCK CREBBP TNRC6A	5.22e-12	376	40	12	int:TLE3
Interaction	EGR2 interactions	TRERF1 NCOA1 NCOA3 KMT2C NCOA6 ZFHX3 ARID1B CHD7 CREBBP	4.03e-11	171	40	9	int:EGR2
Interaction	AR interactions	TRERF1 MED12L NCOA1 NCOA3 TARDBP KMT2C NCOA6 ZFHX3 ARID1B CHD7 USP54 DDX17 SOCS6 RUNX1 CREBBP	2.75e-10	992	40	15	int:AR
Interaction	FOS interactions	NCOA1 NCOA3 KMT2C NCOA6 HNF1A ARID1B DDX17 RUNX1 NFAT5 CREBBP	3.85e-10	312	40	10	int:FOS
Interaction	HNF4A interactions	NCOA1 NCOA3 KMT2C NCOA6 HNF1A ARID1B CHD7 TAF4 CREBBP	2.72e-09	275	40	9	int:HNF4A
Interaction	HNF1B interactions	NCOA3 KMT2C HNF1A ZFHX3 ARID1B CHD7 USP54 CREBBP	3.20e-09	190	40	8	int:HNF1B
Interaction	GATA2 interactions	NCOA3 KMT2C NCOA6 ZFHX3 ARID1B CHD7 RUNX1 CREBBP	4.61e-09	199	40	8	int:GATA2
Interaction	FEV interactions	NCOA3 KMT2C NCOA6 ZFHX3 ARID1B CHD7 TAF4 CREBBP	5.38e-09	203	40	8	int:FEV
Interaction	SP7 interactions	TRERF1 NCOA1 NCOA3 KMT2C NCOA6 ARID1B CHD7 CREBBP PYGO1	6.52e-09	304	40	9	int:SP7
Interaction	SOX7 interactions	NCOA1 NCOA3 KMT2C ARID1B CHD7 CREBBP	1.29e-08	82	40	6	int:SOX7
Interaction	CREBBP interactions	TRERF1 NCOA1 NCOA3 NCOA6 HNF1A ARID1B MAML2 DDX17 RUNX1 CLOCK CREBBP	1.54e-08	599	40	11	int:CREBBP
Interaction	CRX interactions	TRERF1 NCOA1 NCOA3 KMT2C ZFHX3 ARID1B CHD7 CREBBP	3.10e-08	254	40	8	int:CRX
Interaction	KAT2B interactions	NCOA1 NCOA3 HNF1A DDX17 USP27X CLOCK CREBBP BUB1B	3.29e-08	256	40	8	int:KAT2B
Interaction	SOX9 interactions	NCOA3 KMT2C NCOA6 ARID1B CHD7 CREBBP	3.58e-08	97	40	6	int:SOX9
Interaction	TLX1 interactions	NCOA3 KMT2C ZFHX3 ARID1B CHD7 CREBBP PYGO1	4.83e-08	175	40	7	int:TLX1
Interaction	NKX2-1 interactions	NCOA1 NCOA3 ZFHX3 CHD7 RUNX1 NUP155 CREBBP	5.86e-08	180	40	7	int:NKX2-1
Interaction	TBXT interactions	NCOA3 KMT2C NCOA6 ARID1B CHD7 CREBBP	1.04e-07	116	40	6	int:TBXT
Interaction	PAX7 interactions	NCOA3 KMT2C ZFHX3 ARID1B CHD7 CREBBP	1.55e-07	124	40	6	int:PAX7
Interaction	SMG7 interactions	NCOA1 NCOA3 NCOA6 ARID1B TNRC6C CREBBP AMOT TNRC6A	1.79e-07	319	40	8	int:SMG7
Interaction	PAX9 interactions	NCOA3 KMT2C NCOA6 ZFHX3 ARID1B CHD7	2.06e-07	130	40	6	int:PAX9
Interaction	EYA4 interactions	NCOA1 NCOA3 TNRC6C NUP155 CREBBP AMOT TNRC6A	4.51e-07	243	40	7	int:EYA4
Interaction	HNF1A interactions	NCOA1 NCOA3 KMT2C HNF1A CREBBP	5.12e-07	80	40	5	int:HNF1A
Interaction	GSC interactions	NCOA3 KMT2C ZFHX3 ARID1B CREBBP	7.80e-07	87	40	5	int:GSC
Interaction	YAP1 interactions	TRERF1 TARDBP KMT2C NCOA6 ARID1B DDX17 TAF4 RUNX1 NFAT5 CREBBP AMOT BUB1B	8.44e-07	1095	40	12	int:YAP1
Interaction	FOXI1 interactions	NCOA3 KMT2C ARID1B USP54 CREBBP	1.03e-06	92	40	5	int:FOXI1
Interaction	TNRC6A interactions	KMT2C NCOA6 USP54 TNRC6C NUP155 AMOT TNRC6A	1.17e-06	280	40	7	int:TNRC6A
Interaction	SOX17 interactions	NCOA3 KMT2C NCOA6 ARID1B CHD7	1.21e-06	95	40	5	int:SOX17
Interaction	TEAD1 interactions	NCOA1 KMT2C ZFHX3 ARID1B CHD7 CREBBP	1.22e-06	176	40	6	int:TEAD1
Interaction	RBBP5 interactions	KMT2C NCOA6 CHD7 TAF4 RUNX1 CREBBP TNRC6A	1.38e-06	287	40	7	int:RBBP5
Interaction	SS18L1 interactions	CSTF2 ARID1B USP54 CREBBP C1orf94	1.41e-06	98	40	5	int:SS18L1
Interaction	NUP35 interactions	NCOA3 KMT2C NCOA6 ARID1B NUP155 CREBBP MAML3 TNRC6A	1.53e-06	424	40	8	int:NUP35
Interaction	MYOD1 interactions	NCOA1 NCOA3 KMT2C ARID1B RUNX1 CREBBP	2.15e-06	194	40	6	int:MYOD1
Interaction	PPARG interactions	NCOA1 NCOA3 KMT2C NCOA6 ARID1B DDX17 CREBBP	2.15e-06	307	40	7	int:PPARG
Interaction	RORB interactions	NCOA1 NCOA3 NCOA6 CLOCK	2.23e-06	47	40	4	int:RORB
Interaction	PAX8 interactions	NCOA3 KMT2C ARID1B CHD7 CREBBP	2.61e-06	111	40	5	int:PAX8
Interaction	THRA interactions	NCOA1 NCOA3 NCOA6 CREBBP AMOT	2.61e-06	111	40	5	int:THRA
Interaction	TBR1 interactions	NCOA3 KMT2C ZFHX3 ARID1B CHD7	2.85e-06	113	40	5	int:TBR1
Interaction	CEBPA interactions	TRERF1 NCOA1 NCOA3 KMT2C NCOA6 HNF1A ARID1B CHD7 DDX17 TAF4 RUNX1 CREBBP	3.25e-06	1245	40	12	int:CEBPA
Interaction	JUN interactions	NCOA1 NCOA3 KMT2C NCOA6 TAF4 RUNX1 NFAT5 CREBBP	3.29e-06	470	40	8	int:JUN
Interaction	RARA interactions	NCOA1 NCOA3 NCOA6 RUNX1 CLOCK CREBBP	4.81e-06	223	40	6	int:RARA
Interaction	ERG interactions	NCOA3 KMT2C NCOA6 ARID1B CHD7 CREBBP	4.81e-06	223	40	6	int:ERG
Interaction	NCOA3 interactions	NCOA1 NCOA3 HNF1A ARID1B MN1 CREBBP	4.94e-06	224	40	6	int:NCOA3
Interaction	VDR interactions	NCOA1 NCOA3 NCOA6 RUNX1 CREBBP	5.06e-06	127	40	5	int:VDR
Interaction	CIC interactions	TARDBP HNF1A ZFHX3 CHD7 DDX17 TAF4 RUNX1 NUP155 NFAT5	5.29e-06	673	40	9	int:CIC
Interaction	PAX6 interactions	NCOA3 KMT2C NCOA6 ZFHX3 ARID1B CHD7 CREBBP	6.85e-06	366	40	7	int:PAX6
Interaction	EWSR1 interactions	CSTF2 NCOA3 TARDBP NCOA6 DDX17 TAF4 RUNX1 CREBBP HERPUD1 AMOT	7.95e-06	906	40	10	int:EWSR1
Interaction	CDC16 interactions	USP54 TAF4 RUNX1 CREBBP BUB1B TNRC6A	8.44e-06	246	40	6	int:CDC16
Interaction	NCOA6 interactions	NCOA1 KMT2C NCOA6 CREBBP TNRC6A	9.67e-06	145	40	5	int:NCOA6
Interaction	GCM1 interactions	NCOA3 KMT2C ARID1B CREBBP	9.89e-06	68	40	4	int:GCM1
Interaction	TBP interactions	NCOA1 NCOA3 TARDBP NCOA6 TAF4 CREBBP	9.90e-06	253	40	6	int:TBP
Interaction	NCOA1 interactions	NCOA1 NCOA3 NCOA6 HNF1A CREBBP	9.99e-06	146	40	5	int:NCOA1
Interaction	EP300 interactions	TRERF1 NCOA1 NCOA3 NCOA6 HNF1A MAML2 DDX17 RUNX1 CLOCK MN1 CREBBP AMOT	1.09e-05	1401	40	12	int:EP300
Interaction	KDM1A interactions	TRERF1 NCOA3 ZFHX3 CHD7 SOCS6 CLOCK AMOT PHC1 BUB1B TNRC6A	1.11e-05	941	40	10	int:KDM1A
Interaction	SOX2 interactions	TRERF1 NCOA3 TARDBP KMT2C NCOA6 ZFHX3 ARID1B CHD7 DDX17 RUNX1 CLOCK TNRC6A	1.27e-05	1422	40	12	int:SOX2
Interaction	ASH2L interactions	KMT2C NCOA6 CHD7 TAF4 RUNX1 TNRC6A	1.29e-05	265	40	6	int:ASH2L
Interaction	ARID1A interactions	NCOA1 ARID1B CHD7 RUNX1 CREBBP TNRC6A	1.62e-05	276	40	6	int:ARID1A
Interaction	ANAPC7 interactions	TAF4 MN1 CREBBP BUB1B TNRC6A	1.65e-05	162	40	5	int:ANAPC7
Interaction	WWTR1 interactions	CSTF2 NCOA6 ARID1B RUNX1 CLOCK CREBBP AMOT	1.72e-05	422	40	7	int:WWTR1
Interaction	RXRA interactions	NCOA1 NCOA3 NCOA6 CLOCK CREBBP	2.03e-05	169	40	5	int:RXRA
Interaction	KMT2D interactions	KMT2C NCOA6 HNF1A NUP155 CREBBP	2.03e-05	169	40	5	int:KMT2D
Interaction	TLX3 interactions	NCOA3 KMT2C NCOA6 ZFHX3 ARID1B CHD7	2.19e-05	291	40	6	int:TLX3
Interaction	TLE5 interactions	MED12L CSTF2 HNF1A ZFHX3 USP54 RUNX1 C1orf94	2.35e-05	443	40	7	int:TLE5
Interaction	PAX2 interactions	NCOA3 KMT2C ARID1B CHD7	2.40e-05	85	40	4	int:PAX2
Interaction	IRF4 interactions	NCOA3 KMT2C ARID1B CHD7	2.40e-05	85	40	4	int:IRF4
Interaction	SMAD3 interactions	NCOA1 NCOA3 NCOA6 ZFHX3 ARID1B RUNX1 CREBBP	2.49e-05	447	40	7	int:SMAD3
Interaction	LHX2 interactions	KMT2C ZFHX3 ARID1B CHD7 PYGO1	2.97e-05	183	40	5	int:LHX2
Interaction	GATA3 interactions	NCOA3 TARDBP ARID1B CHD7 CREBBP	3.30e-05	187	40	5	int:GATA3
Interaction	KMT2A interactions	KMT2C NCOA6 RUNX1 CLOCK CREBBP SGTA	3.35e-05	314	40	6	int:KMT2A
Interaction	MPHOSPH9 interactions	TNRC6C NUP155 AMOT TNRC6A	3.72e-05	95	40	4	int:MPHOSPH9
Interaction	KLF5 interactions	NCOA3 KMT2C NCOA6 ARID1B CREBBP	4.03e-05	195	40	5	int:KLF5
Interaction	WDR5 interactions	TARDBP KMT2C NCOA6 CHD7 DDX17 TAF4 RUNX1 NUP155 CREBBP TNRC6A	4.29e-05	1101	40	10	int:WDR5
Interaction	DTX2 interactions	NCOA3 USP54 RUNX1 NUP155 C1orf94 TNRC6A	4.42e-05	330	40	6	int:DTX2
Interaction	HOXB2 interactions	NCOA1 ARID1B CREBBP	4.94e-05	36	40	3	int:HOXB2
Interaction	PHF21A interactions	ZFHX3 CHD7 CLOCK AMOT BUB1B TNRC6A	5.48e-05	343	40	6	int:PHF21A
Interaction	SMARCC2 interactions	NCOA3 ARID1B CHD7 DDX17 RUNX1 CREBBP	6.43e-05	353	40	6	int:SMARCC2
Interaction	C10orf88 interactions	TNRC6C NUP155 SSX3 PHC1	7.33e-05	113	40	4	int:C10orf88
Interaction	NPAS2 interactions	NCOA3 CLOCK CREBBP	7.88e-05	42	40	3	int:NPAS2
Interaction	CHMP2A interactions	CSTF2 TARDBP USP54 DDX17	8.39e-05	117	40	4	int:CHMP2A
Interaction	ANAPC2 interactions	CSTF2 USP54 CREBBP BUB1B TNRC6A	9.55e-05	234	40	5	int:ANAPC2
Interaction	ETS1 interactions	NCOA1 NCOA3 ARID1B CREBBP	9.56e-05	121	40	4	int:ETS1
Interaction	RORC interactions	NCOA3 NCOA6 CLOCK	9.70e-05	45	40	3	int:RORC
Interaction	NR3C1 interactions	NCOA1 NCOA3 NCOA6 ARID1B CHD7 CREBBP C1orf94 MAML3 SGTA	9.78e-05	974	40	9	int:NR3C1
Interaction	SMARCC1 interactions	NCOA1 NCOA3 ARID1B CHD7 RUNX1 CREBBP	1.02e-04	384	40	6	int:SMARCC1
Interaction	SMAD2 interactions	NCOA3 KMT2C NCOA6 ARID1B RUNX1 CREBBP	1.04e-04	385	40	6	int:SMAD2
Interaction	PRRC2A interactions	TARDBP USP54 TNRC6C RUNX1 CLOCK TNRC6A	1.10e-04	389	40	6	int:PRRC2A
Interaction	CDC23 interactions	USP54 TAF4 SOCS6 BUB1B TNRC6A	1.12e-04	242	40	5	int:CDC23
Interaction	NR1I2 interactions	NCOA1 NCOA3 NCOA6	1.18e-04	48	40	3	int:NR1I2
Interaction	R3HDM2 interactions	USP54 TNRC6C C1orf94 TNRC6A	1.22e-04	129	40	4	int:R3HDM2
Interaction	BRCA1 interactions	CSTF2 NCOA1 NCOA3 TARDBP DDX17 TNRC6C RUNX1 NUP155 CREBBP TNRC6A	1.23e-04	1249	40	10	int:BRCA1
Interaction	TCHP interactions	TNRC6C NUP155 AMOT TNRC6A	1.30e-04	131	40	4	int:TCHP
Interaction	PAGR1 interactions	NCOA1 KMT2C NCOA6	1.41e-04	51	40	3	int:PAGR1
Interaction	KMT2C interactions	KMT2C NCOA6 HNF1A TNRC6A	1.42e-04	134	40	4	int:KMT2C
Interaction	HELZ interactions	TARDBP TNRC6C NUP155 CREBBP TNRC6A	1.48e-04	257	40	5	int:HELZ
Interaction	TLE2 interactions	USP54 DDX17 RUNX1 CLOCK	1.50e-04	136	40	4	int:TLE2
Interaction	ESRRB interactions	CSTF2 NCOA3 KMT2C TAF4 RUNX1	1.62e-04	262	40	5	int:ESRRB
Interaction	NCOA2 interactions	NCOA1 NCOA3 NCOA6 CREBBP	1.73e-04	141	40	4	int:NCOA2
Interaction	MED23 interactions	MED12L NCOA6 ZFHX3 CREBBP TNRC6A	1.74e-04	266	40	5	int:MED23
Interaction	NFIB interactions	NCOA3 KMT2C ARID1B CREBBP	1.77e-04	142	40	4	int:NFIB
Interaction	TLX2 interactions	KMT2C ZFHX3 ARID1B CHD7	1.77e-04	142	40	4	int:TLX2
Interaction	RNF43 interactions	USP54 DDX17 NUP155 AMOT SGTA TNRC6A	1.82e-04	427	40	6	int:RNF43
GeneFamily	Zinc fingers ZZ-type\|Lysine acetyltransferases	NCOA1 NCOA3 CLOCK CREBBP	1.08e-08	17	28	4	486
GeneFamily	Ataxins\|Trinucleotide repeat containing	NCOA3 TNRC6C MAML3 TNRC6A	5.69e-08	25	28	4	775
GeneFamily	Basic helix-loop-helix proteins	NCOA1 NCOA3 CLOCK	6.43e-04	110	28	3	420
GeneFamily	GATA zinc finger domain containing\|Myb/SANT domain containing	TRERF1 CHD7	3.04e-03	53	28	2	532
GeneFamily	Ubiquitin specific peptidases	USP54 USP27X	3.38e-03	56	28	2	366
GeneFamily	PHD finger proteins	KMT2C PYGO1	8.52e-03	90	28	2	88
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	NCOA1 NCOA3 ZFHX3 DDX17 TAF4 SOCS6 RUNX1 CLOCK MN1 CREBBP BUB1B	4.11e-08	856	40	11	M4500
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	NCOA1 NCOA3 TAF4 RUNX1 CLOCK CREBBP BUB1B	6.02e-06	466	40	7	M13522
Coexpression	GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP	MED12L KMT2C CHD7 NFAT5 CREBBP	7.82e-06	180	40	5	M8239
Coexpression	GRESHOCK_CANCER_COPY_NUMBER_UP	HNF1A MAML2 RUNX1 MN1 CREBBP BUB1B	9.02e-06	323	40	6	M9150
Coexpression	IKEDA_MIR30_TARGETS_UP	SOCS6 NFAT5 CLOCK TNRC6A	2.94e-05	116	40	4	M2379
Coexpression	IKEDA_MIR30_TARGETS_UP	SOCS6 NFAT5 CLOCK TNRC6A	3.04e-05	117	40	4	MM931
Coexpression	KRASNOSELSKAYA_ILF3_TARGETS_DN	TAF4 MN1 CREBBP	4.78e-05	46	40	3	M12166
Coexpression	GENTILE_UV_HIGH_DOSE_DN	NCOA3 TARDBP DDX17 RUNX1 HERPUD1	7.55e-05	289	40	5	M13630
Coexpression	GSE7768_OVA_ALONE_VS_OVA_WITH_LPS_IMMUNIZED_MOUSE_WHOLE_SPLEEN_6H_UP	NCOA1 NCOA3 SOCS6 BUB1B	1.27e-04	169	40	4	M6851
Coexpression	GSE37301_CD4_TCELL_VS_RAG2_KO_NK_CELL_DN	NCOA1 KMT2C ARID1B TNRC6C	1.62e-04	180	40	4	M8906
Coexpression	THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_NONRESPONDER_7DY_DN	ZFHX3 CLOCK HERPUD1	1.83e-04	72	40	3	M40882
Coexpression	GSE30971_WBP7_HET_VS_KO_MACROPHAGE_4H_LPS_STIM_DN	ZFHX3 DDX17 HERPUD1 MAML3	2.29e-04	197	40	4	M8726
Coexpression	GSE4984_LPS_VS_VEHICLE_CTRL_TREATED_DC_DN	TRERF1 NCOA6 RUNX1 NFAT5	2.33e-04	198	40	4	M6511
Coexpression	GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_6H_DN	NCOA1 DDX17 RUNX1 NFAT5	2.38e-04	199	40	4	M6172
Coexpression	GSE339_CD4POS_VS_CD4CD8DN_DC_IN_CULTURE_DN	MED12L NCOA1 AMOT PHC1	2.42e-04	200	40	4	M5124
Coexpression	GSE16385_ROSIGLITAZONE_IL4_VS_IFNG_TNF_STIM_MACROPHAGE_UP	NCOA3 CHD7 CREBBP HERPUD1	2.42e-04	200	40	4	M8030
Coexpression	GSE16385_ROSIGLITAZONE_IL4_VS_IL4_ALONE_STIM_MACROPHAGE_12H_UP	NCOA3 TARDBP NCOA6 HERPUD1	2.42e-04	200	40	4	M8026
Coexpression	GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_TRICHOSTATINA_CD8_TCELL_UP	NCOA1 NCOA3 CREBBP HERPUD1	2.42e-04	200	40	4	M3614
Coexpression	GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_48H_UP	NCOA1 USP27X NFAT5 BUB1B	2.42e-04	200	40	4	M6044
Coexpression	TABULA_MURIS_SENIS_PANCREAS_PANCREATIC_BETA_CELL_AGEING	NCOA1 CHD7 DDX17 HERPUD1	3.03e-04	212	40	4	MM3816
ToppCell	nucseq\|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	KMT2C ARID1B MAML2 RUNX1 NFAT5 MAML3	1.96e-08	193	40	6	779276e775cb2492e8dd36436295a536084a6415
ToppCell	Tracheal-NucSeq\|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations	NCOA1 KMT2C ARID1B MAML2 MAML3 TNRC6A	2.35e-08	199	40	6	94b94b17ca18b8dc27b91da1f2ccf89e03cc7035
ToppCell	Hematolymphoid-Microglia\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	MED12L MAML2 SOCS6 RUNX1 MAML3	9.57e-07	200	40	5	21bcca3b670fe9bac034aef2275d3de4a9a73e2b
ToppCell	Hematolymphoid-Microglia-TYROBP----L1-3\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	MED12L MAML2 SOCS6 RUNX1 MAML3	9.57e-07	200	40	5	a20dce14f94777687aad57d6fbe3258ad376f63f
ToppCell	Hematolymphoid-Microglia-TYROBP--\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	MED12L MAML2 SOCS6 RUNX1 MAML3	9.57e-07	200	40	5	dc344b3ec51d506952e38f0b3a7795d65f9dd4eb
ToppCell	Hematolymphoid-Microglia-TYROBP---\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	MED12L MAML2 SOCS6 RUNX1 MAML3	9.57e-07	200	40	5	a8646d0fca99f10827c2d2a12e584660ef7155f1
ToppCell	Hematolymphoid-Microglia-TYROBP-\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	MED12L MAML2 SOCS6 RUNX1 MAML3	9.57e-07	200	40	5	3bba5219453322198e8fdb0921d5f8c403598751
ToppCell	Hematolymphoid-Microglia-TYROBP\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	MED12L MAML2 SOCS6 RUNX1 MAML3	9.57e-07	200	40	5	33036d21c1c82109284473a515c4f890b33fdd5c
ToppCell	facs-Brain_Myeloid-Cerebellum-3m-Myeloid-microglial_cell\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MED12L CHD7 MAML2 RUNX1	1.81e-05	175	40	4	1ea6cf9da26601646f57fa14d558a5e9e1f0b345
ToppCell	TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma-7\|TCGA-Colorectal / Sample_Type by Project: Shred V9	NCOA3 NCOA6 TAF4 USP27X	1.94e-05	178	40	4	edc76b8f15056ec1c9a1c61a048b6331a92592d6
ToppCell	pdx\|World / Sample and Cell Type and Tumor Cluster (all cells)	NCOA3 ARID1B NFAT5 MAML3	2.30e-05	186	40	4	de8e538c8767d41b8a52f5e58ba1affd4e7244c4
ToppCell	pdx-Tumor_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	NCOA3 ARID1B NFAT5 MAML3	2.30e-05	186	40	4	0b88a87158a9ca8de3bf40a4ff1687150707a5f0
ToppCell	CD8+_Memory_T_cell-CV-7\|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster	NCOA3 DDX17 NUP155 NFAT5	2.55e-05	191	40	4	9454f642c3621370fa23640b631301346b300950
ToppCell	Bronchial-NucSeq\|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations	NCOA1 ARID1B MAML2 MAML3	2.82e-05	196	40	4	ab53c742866945545a92e2e61850d63c80d9a2a6
ToppCell	Parenchymal-NucSeq\|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations	NCOA1 ARID1B MAML2 MAML3	2.94e-05	198	40	4	1996373bdccc55aac347d349bd22f6aad6d0c668
ToppCell	Sepsis-Int-URO-Myeloid-tDC\|Int-URO / Disease, condition lineage and cell class	MED12L SOCS6 HERPUD1 BUB1B	3.05e-05	200	40	4	f5d0497a72da21cad24e0ef51c3dc4d024dbf294
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_low-phase\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CSTF2 TARDBP BUB1B	2.91e-04	144	40	3	f6061dd965a2b2fe6ad864f8aecc06d2e74881ce
ToppCell	LPS-IL1RA-Myeloid-Monocytes,_Macrophages-Erythroid\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MED12L USP27X MN1	2.91e-04	144	40	3	7c471e332f87d60f4dbed01f3e66bf39995218d0
ToppCell	BAL-Control-cDC_4\|Control / Compartment, Disease Groups and Clusters	TARDBP NCOA6 ZFHX3	2.97e-04	145	40	3	3b2a2965dc18abd39d5ed70c0fcad0210e7f12c8
ToppCell	facs-Pancreas-Exocrine-3m-Epithelial-nan\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AFF2 NFAT5 TMEM212	3.61e-04	155	40	3	441fcb6d05364fc6f4973f0b973f1a80b573ce1f
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Myocytic\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MED12L ZFHX3 AFF2	3.68e-04	156	40	3	6365b69ede98bc866e996bc52736b00401aacf6f
ToppCell	COVID-19-Mast_cells\|COVID-19 / group, cell type (main and fine annotations)	MED12L AFF2 MAML3	3.68e-04	156	40	3	159504d43421ee83b9ab484816333ae549c9c2fd
ToppCell	COVID-19-Mast_cells-Mast_cells\|COVID-19 / group, cell type (main and fine annotations)	MED12L AFF2 MAML3	3.68e-04	156	40	3	bc10b94673184ef384c6665b16a1209a8975a4f1
ToppCell	10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8\|bone_marrow / Manually curated celltypes from each tissue	KMT2C MAML2 DDX17	3.68e-04	156	40	3	1545169694f686d28648a68b552c2ae606599d66
ToppCell	367C-Lymphocytic-NK_cells-NK_cell_B1\|367C / Donor, Lineage, Cell class and subclass (all cells)	NCOA6 USP54 NUP155	4.03e-04	161	40	3	f470b662566131dfe69a2fd01186ac8491196396
ToppCell	droplet-Liver-LIVER_HEP-30m-Myeloid-macrophage/monocyte\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RUNX1 CREBBP MAML3	4.11e-04	162	40	3	93bd29c52846c3156b8b0d2e39c552373efdfe93
ToppCell	Int-URO-Myeloid-tDC\|Int-URO / Disease, Lineage and Cell Type	MED12L HERPUD1 BUB1B	4.33e-04	165	40	3	9803c3db6cdcf925bea7d9c382bf4fd05acf3509
ToppCell	nucseq-Immune-Hematopoietic-Granulocytic\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	TRERF1 MED12L MAML3	4.33e-04	165	40	3	37615622c736e43260c38016e7c9e565ac97a3e8
ToppCell	nucseq-Immune-Hematopoietic-Granulocytic-Mast/Basophil\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	TRERF1 MED12L MAML3	4.33e-04	165	40	3	640bb71e74a61df2fcb01ceeabe4c493ef836b21
ToppCell	nucseq-Immune-Hematopoietic\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	TRERF1 MED12L MAML3	4.33e-04	165	40	3	f3df74b5763130c71c0a482a3a23f6b22acc2892
ToppCell	3'_v3-lymph-node_spleen-Hematopoietic_progenitors-Progenitor\|lymph-node_spleen / Manually curated celltypes from each tissue	MED12L MN1 MAML3	4.49e-04	167	40	3	cb396f3edb9e8fdc316091e8e193dbba50e0be0c
ToppCell	390C-Lymphocytic-NK_cells-NK_cell_D3\|NK_cells / Donor, Lineage, Cell class and subclass (all cells)	MED12L ALPK1 MAML3	4.56e-04	168	40	3	6501495b7ad252af330b18011696c43031541018
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ARID1B DDX17 NFAT5	4.72e-04	170	40	3	928e42c51a7079c506f21c669c4e4c1a0df84d77
ToppCell	PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_prolif\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MED12L RUNX1 BUB1B	4.81e-04	171	40	3	bf475a69db04d4a886e442704955c6a96ff0de46
ToppCell	Immune-mast_cell\|World / Lineage, Cell type, age group and donor	TRERF1 MED12L AFF2	4.89e-04	172	40	3	6e8e0aac5a20dbc789bf8c6916833bb8709a411a
ToppCell	5'-Adult-LargeIntestine-Hematopoietic-B_cells-Cycling_B_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MED12L AFF2 BUB1B	4.97e-04	173	40	3	b7e0193fd4983cb38d1bee441f608f73ee8743b9
ToppCell	Control-B_cells-Plasma_cells\|Control / group, cell type (main and fine annotations)	NCOA3 AFF2 HERPUD1	5.14e-04	175	40	3	fb23858cfce71509cafbe0d9728e678012ff2962
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1_PAX6_GRIP2\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	MAML2 MN1 MAML3	5.14e-04	175	40	3	0c648e7f67ffbe3b476a2ca77d246554f8cd1882
ToppCell	390C-Lymphocytic-CD4_T-cell-Proliferating_T_cell\|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)	MED12L AFF2 BUB1B	5.23e-04	176	40	3	941e8724b6f680719ef2a4f190f943b205bb9e78
ToppCell	CV-Severe-7\|CV / Virus stimulation, Condition and Cluster	NCOA3 CHD7 NFAT5	5.23e-04	176	40	3	3de0c7d77210049e5616db21eed1490a17a5ec2d
ToppCell	CV-Severe-7\|Severe / Virus stimulation, Condition and Cluster	NCOA3 CHD7 NFAT5	5.31e-04	177	40	3	82fdd6185b368f54f03de389427cbe3071d21a99
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1_PAX6_CA4\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	MAML2 MN1 MAML3	5.40e-04	178	40	3	e86ed30652c2de70f16430f04b78789b87df4af2
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_SST_CXCL14\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	AFF2 MN1 MAML3	5.49e-04	179	40	3	c7afbd10072d36a35cd20ae73670d76b9cefd22d
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_SST_CXCL14\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	AFF2 MN1 MAML3	5.58e-04	180	40	3	b6efdb4d319ef6f87f559acd974e5a71b06a2322
ToppCell	3'-Pediatric_IBD-SmallIntestine-Hematopoietic-B_cells-Cycling_plasma_cell\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	AFF2 HERPUD1 BUB1B	5.58e-04	180	40	3	ce2fc270f9d9110c2544083f61936b0b7d3b7eb3
ToppCell	RA-01._Fibroblast_I\|World / Chamber and Cluster_Paper	ZFHX3 MAML2 AFF2	5.67e-04	181	40	3	2b6ddeb53a79a658e2ba78527ff48c155b20daa6
ToppCell	TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-5\|TCGA-Liver / Sample_Type by Project: Shred V9	CSTF2 TARDBP BUB1B	5.85e-04	183	40	3	f604a8b62c7088fad8365dbf8d910fc980bd3ba8
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	MAML2 TNRC6C TNRC6A	5.85e-04	183	40	3	f2ef110bf29b1a8276ef216238363e542db262c1
ToppCell	pdx-Tumor_cells-T0\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	NCOA3 RUNX1 NFAT5	6.04e-04	185	40	3	1d874608aa2062024323512f68889219471b2f00
ToppCell	primary_auditory_cortex_(A1C)-Non-neuronal-Endothelial_Myeloid\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ZFHX3 MAML2 RUNX1	6.23e-04	187	40	3	5ce7cf02990465b6f793205e4be07e8337b3570a
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	MAML2 MN1 MAML3	6.23e-04	187	40	3	d2ffb2f34f07b0dd5d3cb3ee0275f46ebecf4146
ToppCell	5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.0.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NCOA1 CHD7 AMOT	6.23e-04	187	40	3	f5a202d5f8eb57b57d80815ce98774e04c387383
ToppCell	primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CHD7 MAML2 USP54	6.33e-04	188	40	3	b04fd6a724c117eb9a979c29b91f90113feb7a5c
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	KMT2C ARID1B NFAT5	6.33e-04	188	40	3	ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCell	B_cells-Naive_B_cells_\|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	NCOA3 CHD7 HERPUD1	6.33e-04	188	40	3	d1bc1316bbb8cfc39acc70f8680b14d19f536997
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1_PAX6_CA4\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	MAML2 MN1 MAML3	6.33e-04	188	40	3	ee572246e0c2f41bdbc29a03edc67b831af95c09
ToppCell	kidney_cells-Hypertensive_with+without-CKD\|kidney_cells / Celltypes from Cells and Nuclei per compartment and clinical group	ARID1B DDX17 NFAT5	6.33e-04	188	40	3	90188b60ff893754f7938fe8edab79758827168e
ToppCell	nucseq-Immune-Immune_Myeloid-Myeloid_Dendritic-cDC1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	TRERF1 MED12L RUNX1	6.33e-04	188	40	3	d5ce3ffe783c322b4765b790e861727e46bc34b3
ToppCell	Somatosensory_Cortex_(S1)-Non-neuronal\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ZFHX3 CHD7 MAML2	6.43e-04	189	40	3	42ab4cc5fbf8580841f31889446fe4499df1a464
ToppCell	renal_medulla_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	ARID1B MAML2 NFAT5	6.43e-04	189	40	3	830d9cd0dd706bce22eb2416f07b2c31c870a05a
ToppCell	Somatosensory_Cortex_(S1)-Non-neuronal-Endothelial_Myeloid-Micro-Microglia-Micro_L1-6_C1QC\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ZFHX3 MAML2 RUNX1	6.43e-04	189	40	3	389ccb68acb82893709f256315111470cf4beed3
ToppCell	Somatosensory_Cortex_(S1)-Non-neuronal-Endothelial_Myeloid-Micro\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ZFHX3 MAML2 RUNX1	6.43e-04	189	40	3	7ac78441a15a82218deaafd47accff2ea5c8de20
ToppCell	Somatosensory_Cortex_(S1)-Non-neuronal-Endothelial_Myeloid-Micro-Microglia\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ZFHX3 MAML2 RUNX1	6.43e-04	189	40	3	58465b9407fbce91cca8f199950d6e0054c38fbc
ToppCell	Somatosensory_Cortex_(S1)-Non-neuronal-Endothelial_Myeloid\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ZFHX3 MAML2 RUNX1	6.53e-04	190	40	3	d4f954e0748898df69e1710df558564db703dd61
ToppCell	367C-Lymphocytic-NK_cells-NK_cell_B1\|NK_cells / Donor, Lineage, Cell class and subclass (all cells)	NCOA6 USP54 NUP155	6.53e-04	190	40	3	2434b8ad2976eab7d9147012c28454ab29670709
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Neuronal-Immature_INs\|3.5_mon / Sample Type, Dataset, Time_group, and Cell type.	ZFHX3 ARID1B CHD7	6.53e-04	190	40	3	842760bfe0a52e67bad800efa7d99448a4a23ebb
ToppCell	Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CHD7 MAML2 USP54	6.63e-04	191	40	3	2110a1dd10730ad7ee7a265fb1716ab3ddafcf4a
ToppCell	367C-Lymphocytic-NK_cells-NK_cell_B1\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	NCOA6 USP54 NUP155	6.63e-04	191	40	3	39ef8e1d7cc3ebb11717e8a55501515e3b72b177
ToppCell	LV-08._Macrophage\|World / Chamber and Cluster_Paper	MED12L RUNX1 MAML3	6.63e-04	191	40	3	e7a0bc46ba9ba772636a583f3387748418e18832
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c05-MZB1-XBP1\|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k)	NCOA3 HERPUD1 BUB1B	6.63e-04	191	40	3	208cd307826b5af89f8f10c0c915f90f80a25c6c
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	MAML2 TNRC6C TNRC6A	6.63e-04	191	40	3	696921a4f160b6b55698652488ed781e855e5e51
ToppCell	B_cells\|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	NCOA3 CHD7 HERPUD1	6.63e-04	191	40	3	72e3191990973440e4f91427208df360f73e4f41
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	AFF2 MN1 MAML3	6.63e-04	191	40	3	7b386512284dfaa0e95358b28ee82632ee965e64
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	ARID1B CHD7 HERPUD1	6.73e-04	192	40	3	446c61c0d6ba89c619efe87ee495951299953981
ToppCell	RV-08._Macrophage\|World / Chamber and Cluster_Paper	RUNX1 MAML3 BUB1B	6.73e-04	192	40	3	a1b5dc5beb97a23729b97b54fb4574d10d8fbfb3
ToppCell	human_hepatoblastoma-Tumor_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	ARID1B NFAT5 TNRC6A	6.73e-04	192	40	3	916fbec1c7ab7969bda711886ac88e877e30c280
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8\|lymph-node_spleen / Manually curated celltypes from each tissue	KMT2C MAML2 DDX17	6.73e-04	192	40	3	47646d7e4990be85072987f92bf18d52f8da752e
ToppCell	renal_cortex_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	ARID1B MAML2 TNRC6A	6.73e-04	192	40	3	e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	ARID1B CHD7 HERPUD1	6.83e-04	193	40	3	bbea475d2c4c7b29674ff302529f8f83dd666dcb
ToppCell	LA-14._Fibroblast_III\|LA / Chamber and Cluster_Paper	ZFHX3 ARID1B RUNX1	6.83e-04	193	40	3	7426c291bac59e539c427bcaae18abc7d397d44e
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MAML2 NFAT5 AMOT	6.83e-04	193	40	3	ffa1932da2979d7b63dbac32eb5788346a3f5b2a
ToppCell	mild_COVID-19-B_memory\|mild_COVID-19 / disease group, cell group and cell class (v2)	NCOA3 CHD7 HERPUD1	6.83e-04	193	40	3	7e6fe70928a50b0a8f12220e572c07c5670d092e
ToppCell	human_hepatoblastoma\|World / Sample and Cell Type and Tumor Cluster (all cells)	ARID1B NFAT5 TNRC6A	6.83e-04	193	40	3	e6a688bc834f845ff64dae1be64f073eec5091a1
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	ARID1B CHD7 HERPUD1	6.83e-04	193	40	3	f4135615ee0118eec9e221becdd67888e0c2a112
ToppCell	Smart-seq2-spleen_(Smart-seq2)-lymphocytic-B_lymphocytic\|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	NCOA3 CHD7 HERPUD1	6.93e-04	194	40	3	b700381f8337b4c6aa50d09ab5bfcd59f2fb2cf3
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MAML2 NFAT5 AMOT	6.93e-04	194	40	3	8ddcaaf24cee6e30d5be52c0cbf778cfba309c53
ToppCell	LA-14._Fibroblast_III\|World / Chamber and Cluster_Paper	ZFHX3 ARID1B RUNX1	6.93e-04	194	40	3	803fa83ceada17c38ca9f933b888f7e7b0b90761
ToppCell	3'-Child04-06-SmallIntestine-Hematopoietic-B_cells-LZ_GC_cell\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MED12L NCOA3 HERPUD1	7.04e-04	195	40	3	cccc9c70bb8f6df8c6ab94534c17475af1d3e224
ToppCell	RV-02._Fibroblast_II\|World / Chamber and Cluster_Paper	NCOA1 ZFHX3 MAML2	7.04e-04	195	40	3	ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MED12L MAML2 DDX17	7.04e-04	195	40	3	a38d9dc6192aea673d96fda6b25e81223fda3abf
ToppCell	RA-02._Fibroblast_II\|RA / Chamber and Cluster_Paper	ZFHX3 ARID1B MAML2	7.04e-04	195	40	3	6a02ebbeb3199447ddce64d92d8809436e040eba
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	NCOA3 CHD7 HERPUD1	7.04e-04	195	40	3	0c49d22c348aec6d8a1a976e7c88d0a3b48a4244
ToppCell	Control-Lymphoid-T\|Lymphoid / Disease state, Lineage and Cell class	TRERF1 MED12L MAML2	7.04e-04	195	40	3	6687e579582d7a239bee80846de0cf827a6f6a62
ToppCell	Mild/Remission-B_naive-8\|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5)	ARID1B MAML3 PHC1	7.04e-04	195	40	3	0a3221e4d1fa31a35868bdda0f0cc873c233b407
ToppCell	facs-Brain_Myeloid-Hippocampus\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MED12L ZFHX3 MAML3	7.04e-04	195	40	3	a1478021a3ed0e779716393124ca2a7770c433b7
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW09-Macroglial-Glia_progenitor_cell\|GW09 / Sample Type, Dataset, Time_group, and Cell type.	NCOA1 TAF4 BEND7	7.14e-04	196	40	3	7be50b9156394dea44d7b8b476d4dd516abfafae
ToppCell	Control-B_naive-8\|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5)	ARID1B HERPUD1 PHC1	7.14e-04	196	40	3	54074da84000e4749ade8acc542f05a275bf829f
ToppCell	RA-02._Fibroblast_II\|World / Chamber and Cluster_Paper	ZFHX3 ARID1B MAML2	7.14e-04	196	40	3	e8cbda03837f1f26470a9d93aa7fdaa04e08e38a
ToppCell	mLN-B_cell-B_cell_cycling\|mLN / Region, Cell class and subclass	MED12L AFF2 BUB1B	7.25e-04	197	40	3	806dddcca85c82bd642008d930c8db16b613d88e
ToppCell	mLN-(2)_B_cell-(24)_B_cell_cycling\|mLN / shred on region, Cell_type, and subtype	MED12L AFF2 BUB1B	7.25e-04	197	40	3	70fff2d6723f259e18e7a21d22dc46d71f0759ce
Computational	Neighborhood of MSH3	HNF1A RUNX1 AFF2 NFAT5 CLOCK AMOT	1.55e-05	243	25	6	MORF_MSH3
Computational	Genes upregulated in subsets of cells of a given type within various tumors	DDX17 RUNX1 NFAT5	2.03e-04	50	25	3	GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_4
Computational	Neighborhood of FOSL1	HNF1A SOCS6 RUNX1 AFF2 NFAT5 CLOCK	2.69e-04	406	25	6	MORF_FOSL1
Computational	Neighborhood of TNFRSF25	HNF1A SOCS6 RUNX1 AFF2 CLOCK	3.16e-04	266	25	5	MORF_TNFRSF25
Computational	Neighborhood of MAGEA9	HNF1A SOCS6 RUNX1 AFF2 NFAT5 CLOCK	3.35e-04	423	25	6	MORF_MAGEA9
Computational	Neighborhood of NOS2A	HNF1A SOCS6 RUNX1 AFF2 CLOCK	4.56e-04	288	25	5	MORF_NOS2A
Drug	AC1L2E0P	TRERF1 NCOA1 NCOA3 NCOA6 DDX17 TAF4 CREBBP	9.64e-07	307	40	7	CID000019390
Drug	glutamin	NCOA1 NCOA3 TARDBP TAF4 AFF2 NFAT5 CREBBP SGTA	1.16e-06	461	40	8	CID000000738
Drug	Ivermectin [70288-86-7]; Down 200; 4.6uM; PC3; HT_HG-U133A	NCOA1 ZFHX3 CHD7 ALPK1 DDX17 SGTA	1.28e-06	200	40	6	5853_DN
Drug	trichostatin A ; Down 200; 1uM; MCF7; HT_HG-U133A_EA	ZFHX3 CHD7 DDX17 TAF4 CREBBP	1.38e-05	176	40	5	981_DN
Drug	Harmaline hydrochloride dihydrate [6027-98-1]; Down 200; 14uM; HL60; HT_HG-U133A	NCOA1 ALPK1 RUNX1 AFF2 TMEM212	2.37e-05	197	40	5	2149_DN
Drug	Tiaprofenic acid [33005-95-7]; Up 200; 15.4uM; MCF7; HT_HG-U133A	HNF1A ALPK1 RUNX1 AFF2 AMOT	2.43e-05	198	40	5	4171_UP
Drug	Aztreonam [78110-38-0]; Down 200; 9.2uM; PC3; HT_HG-U133A	DDX17 SOCS6 RUNX1 NFAT5 SGTA	2.43e-05	198	40	5	5110_DN
Drug	butamben	NCOA1 NCOA3	4.49e-05	6	40	2	ctd:C004605
Drug	androstan-3-ol	NCOA1 NCOA6	4.49e-05	6	40	2	ctd:C000658
Drug	Androstenedione	NCOA1 NCOA3 CREBBP	6.77e-05	45	40	3	ctd:D000735
Drug	AC1ND2OB	NCOA1 NCOA3 DDX17 SOCS6 CREBBP	9.70e-05	265	40	5	CID004568637
Drug	2-(3-hydroxypropoxy)-1,25-dihydroxyvitamin D3	NCOA1 NCOA3	1.64e-04	11	40	2	ctd:C061137
Drug	BM-I	RUNX1 PHC1	1.96e-04	12	40	2	CID016058649
Drug	vorinostat	NCOA1 NCOA3 TAF4 RUNX1 SGTA	2.14e-04	314	40	5	CID000005311
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A	ZFHX3 DDX17 RUNX1 CREBBP	2.27e-04	171	40	4	6879_DN
Drug	dihydroxy-vitamin D3	NCOA1 NCOA3	2.32e-04	13	40	2	ctd:C118756
Drug	AC1L3HJJ	TRERF1 SGTA	2.32e-04	13	40	2	CID000089287
Drug	Asbestos, Crocidolite	TRERF1 NCOA1 NCOA3 ARID1B MAML2 RUNX1 NFAT5 HERPUD1 MAML3	2.43e-04	1241	40	9	ctd:D017638
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	ZFHX3 DDX17 SOCS6 CREBBP	2.54e-04	176	40	4	6784_DN
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A	ZFHX3 DDX17 RUNX1 CREBBP	2.59e-04	177	40	4	6434_DN
Drug	SAHA; Down 200; 10uM; PC3; HT_HG-U133A	ZFHX3 DDX17 SOCS6 CREBBP	2.65e-04	178	40	4	4444_DN
Drug	Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA	NCOA6 ZFHX3 DDX17 CREBBP	2.65e-04	178	40	4	1112_DN
Drug	Phe-gly	NUP155 CREBBP HERPUD1	2.87e-04	73	40	3	CID000098207
Drug	Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A	CHD7 TAF4 CREBBP BUB1B	2.88e-04	182	40	4	3887_DN
Drug	irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A	NCOA3 CHD7 CREBBP BUB1B	2.94e-04	183	40	4	7498_DN
Drug	Benzethonium chloride [121-54-0]; Up 200; 9uM; MCF7; HT_HG-U133A	SOCS6 RUNX1 HERPUD1 TMEM212	3.07e-04	185	40	4	7207_UP
Drug	hemi-BABIM	NCOA3 NCOA6 TAF4	3.11e-04	75	40	3	CID000001281
Drug	Cloperastine hydrochloride [14984-68-0]; Up 200; 11uM; PC3; HT_HG-U133A	HNF1A ZFHX3 RUNX1 HERPUD1	3.13e-04	186	40	4	4271_UP
Drug	retinoic acid; Down 200; 1uM; MCF7; HT_HG-U133A_EA	NCOA1 DDX17 SOCS6 SGTA	3.13e-04	186	40	4	966_DN
Drug	Nifuroxazide [965-52-6]; Down 200; 14.6uM; MCF7; HT_HG-U133A	ALPK1 DDX17 NFAT5 TMEM212	3.26e-04	188	40	4	4835_DN
Drug	Syrosingopine [84-36-6]; Up 200; 6uM; HL60; HG-U133A	HNF1A DDX17 RUNX1 SGTA	3.46e-04	191	40	4	1761_UP
Drug	4-hydroxytestosterone	NCOA1 NCOA3 HNF1A	3.49e-04	78	40	3	CID000160615
Drug	Meclofenoxate hydrochloride [3685-84-5]; Up 200; 13.6uM; PC3; HT_HG-U133A	ZFHX3 RUNX1 SSX3 TMEM212	3.53e-04	192	40	4	4268_UP
Drug	retinoic acid; Down 200; 1uM; MCF7; HT_HG-U133A_EA	ALPK1 DDX17 NFAT5 TMEM212	3.53e-04	192	40	4	849_DN
Drug	ferutinin	NCOA1 NCOA3	3.56e-04	16	40	2	CID000354654
Drug	0173570-0000 [211245-44-2]; Down 200; 1uM; PC3; HT_HG-U133A	NCOA1 ALPK1 RUNX1 TMEM212	3.60e-04	193	40	4	3693_DN
Drug	Cefalonium [5575-21-3]; Down 200; 8.8uM; PC3; HT_HG-U133A	ZFHX3 ALPK1 RUNX1 TMEM212	3.60e-04	193	40	4	4245_DN
Drug	(d,l)-Tetrahydroberberine [522-97-4]; Down 200; 11.8uM; MCF7; HT_HG-U133A	ALPK1 DDX17 RUNX1 AFF2	3.60e-04	193	40	4	4138_DN
Drug	Aldosterone	NCOA1 NCOA6 CREBBP	3.62e-04	79	40	3	ctd:D000450
Drug	Estrone [53-16-7]; Down 200; 14.8uM; PC3; HT_HG-U133A	ALPK1 RUNX1 MN1 TMEM212	3.67e-04	194	40	4	6647_DN
Drug	Nystatine [1400-61-9]; Up 200; 4.4uM; PC3; HT_HG-U133A	RUNX1 SSX3 CREBBP TMEM212	3.67e-04	194	40	4	4223_UP
Drug	Flumethasone [2135-17-3]; Down 200; 9.8uM; PC3; HT_HG-U133A	ALPK1 DDX17 NFAT5 CREBBP	3.67e-04	194	40	4	4272_DN
Drug	Equilin [474-86-2]; Down 200; 15uM; MCF7; HT_HG-U133A	ALPK1 DDX17 RUNX1 AFF2	3.67e-04	194	40	4	5620_DN
Drug	radicicol; Down 200; 0.1uM; PC3; HT_HG-U133A	NCOA1 DDX17 SOCS6 RUNX1	3.67e-04	194	40	4	5952_DN
Drug	Benzethonium chloride [121-54-0]; Down 200; 9uM; MCF7; HT_HG-U133A	DDX17 SOCS6 RUNX1 SSX3	3.67e-04	194	40	4	6070_DN
Drug	Carbamazepine [298-46-4]; Down 200; 17uM; PC3; HT_HG-U133A	ALPK1 DDX17 SSX3 TMEM212	3.75e-04	195	40	4	5093_DN
Drug	Diethylstilbestrol [56-53-1]; Down 200; 15uM; PC3; HT_HG-U133A	ZFHX3 ALPK1 RUNX1 MN1	3.75e-04	195	40	4	3812_DN
Drug	Fendiline hydrochloride [13636-18-5]; Up 200; 11.4uM; HL60; HG-U133A	NCOA3 HNF1A MAML3 SGTA	3.75e-04	195	40	4	1573_UP
Drug	Nalidixic acid sodium salt hydrate; Down 200; 14.6uM; HL60; HT_HG-U133A	ALPK1 SOCS6 RUNX1 TMEM212	3.75e-04	195	40	4	2336_DN
Drug	Metaraminol bitartrate [33402-03-8]; Down 200; 8.6uM; MCF7; HT_HG-U133A	ALPK1 DDX17 NFAT5 TMEM212	3.75e-04	195	40	4	4692_DN
Drug	Pargyline hydrochloride [306-07-0]; Up 200; 20.4uM; HL60; HG-U133A	HNF1A ALPK1 RUNX1 MAML3	3.82e-04	196	40	4	1418_UP
Drug	arachidonic acid sodium salt; Down 200; 10uM; MCF7; HG-U133A	ALPK1 RUNX1 HERPUD1 SGTA	3.82e-04	196	40	4	443_DN
Drug	Vincamine [1617-90-9]; Down 200; 11.2uM; HL60; HT_HG-U133A	NCOA1 SOCS6 NFAT5 TMEM212	3.82e-04	196	40	4	2367_DN
Drug	Tetrahydroalstonine [6474-90-4]; Down 200; 11.4uM; PC3; HT_HG-U133A	ZFHX3 ALPK1 RUNX1 SGTA	3.82e-04	196	40	4	5728_DN
Drug	Gliclazide [21187-98-4]; Up 200; 12.4uM; HL60; HG-U133A	NCOA3 HNF1A RUNX1 NFAT5	3.82e-04	196	40	4	1720_UP
Drug	N6-methyladenosine [1867-73-8]; Down 200; 14.2uM; PC3; HT_HG-U133A	ZFHX3 RUNX1 MN1 TMEM212	3.89e-04	197	40	4	6732_DN
Drug	Piromidic acid [19562-30-2]; Down 200; 13.8uM; PC3; HT_HG-U133A	ZFHX3 ALPK1 SGTA TMEM212	3.89e-04	197	40	4	4575_DN
Drug	nordihydroguaiaretic acid; Up 200; 1uM; MCF7; HT_HG-U133A_EA	ALPK1 RUNX1 AFF2 TMEM212	3.89e-04	197	40	4	1003_UP
Drug	E)-4-hydroxytamoxifen	NCOA1 NCOA3 DDX17 SOCS6	3.89e-04	197	40	4	CID000063062
Drug	Berberine chloride [633-65-8]; Up 200; 10.8uM; HL60; HG-U133A	NCOA3 RUNX1 MAML3 SGTA	3.89e-04	197	40	4	1778_UP
Drug	Gramine [87-52-5]; Down 200; 23uM; HL60; HT_HG-U133A	SOCS6 RUNX1 AFF2 TMEM212	3.89e-04	197	40	4	2143_DN
Drug	chlorpromazine hydrochloride; Up 200; 1uM; PC3; HT_HG-U133A	DDX17 RUNX1 AFF2 HERPUD1	3.89e-04	197	40	4	1217_UP
Drug	Ketoprofen [22071-15-4]; Down 200; 15.8uM; HL60; HT_HG-U133A	NCOA1 DDX17 RUNX1 TMEM212	3.89e-04	197	40	4	2354_DN
Drug	Rescinnamin [24815-24-5]; Down 200; 6.4uM; HL60; HT_HG-U133A	RUNX1 AFF2 SGTA TMEM212	3.89e-04	197	40	4	2130_DN
Drug	fluphenazine dihydrochloride; Up 200; 10uM; PC3; HT_HG-U133A	RUNX1 SSX3 HERPUD1 TMEM212	3.89e-04	197	40	4	1237_UP
Drug	Isoquinoline, 6,7-dimethoxy-1-methyl-1,2,3,4-tetrahydro, hydrochloride; Down 200; 16.4uM; HL60; HT_HG-U133A	NCOA1 NCOA3 DDX17 RUNX1	3.89e-04	197	40	4	2463_DN
Drug	celecoxib; Down 200; 10uM; PC3; HG-U133A	HNF1A ALPK1 RUNX1 SGTA	3.89e-04	197	40	4	482_DN
Drug	Idazoxan hydrochloride [79944-56-2]; Down 200; 16.6uM; HL60; HT_HG-U133A	ALPK1 RUNX1 CLOCK TMEM212	3.97e-04	198	40	4	3088_DN
Drug	Orlistat; Down 200; 10uM; PC3; HT_HG-U133A	HNF1A ALPK1 DDX17 RUNX1	3.97e-04	198	40	4	6388_DN
Drug	Kawain [500-64-1]; Down 200; 17.4uM; HL60; HT_HG-U133A	DDX17 RUNX1 SGTA TMEM212	3.97e-04	198	40	4	2337_DN
Drug	Ald1.1-H_000455; Down 200; 10uM; MCF7; HT_HG-U133A	DDX17 RUNX1 NFAT5 SGTA	3.97e-04	198	40	4	7542_DN
Drug	Trichlorfon [52-68-6]; Down 200; 15.6uM; PC3; HT_HG-U133A	NCOA3 ALPK1 NFAT5 SGTA	3.97e-04	198	40	4	1797_DN
Drug	Amiprilose hydrochloride [60414-06-4]; Down 200; 11.8uM; HL60; HT_HG-U133A	NCOA3 ZFHX3 SOCS6 RUNX1	3.97e-04	198	40	4	3000_DN
Drug	Oxybutynin chloride [1508-65-2]; Up 200; 10.2uM; PC3; HT_HG-U133A	ZFHX3 SOCS6 RUNX1 NFAT5	3.97e-04	198	40	4	7126_UP
Drug	Dapsone [80-08-0]; Down 200; 16.2uM; HL60; HT_HG-U133A	ALPK1 SOCS6 NFAT5 CLOCK	3.97e-04	198	40	4	1868_DN
Drug	Dihydrotestosterone	NCOA1 NCOA3 ZFHX3 CREBBP BUB1B	4.01e-04	360	40	5	ctd:D013196
Drug	AG-013608 [351320-38-2]; Down 200; 10uM; PC3; HT_HG-U133A	DDX17 SOCS6 RUNX1 NFAT5	4.05e-04	199	40	4	5949_DN
Drug	(-)-quinpirole hydrochloride; Down 200; 1uM; MCF7; HG-U133A	HNF1A ALPK1 DDX17 HERPUD1	4.05e-04	199	40	4	456_DN
Drug	Moxisylyte hydrochoride [964-52-3]; Up 200; 12.6uM; PC3; HT_HG-U133A	DDX17 RUNX1 NFAT5 HERPUD1	4.05e-04	199	40	4	1804_UP
Drug	Timolol maleate salt [26921-17-5]; Up 200; 9.2uM; MCF7; HT_HG-U133A	HNF1A ALPK1 RUNX1 TMEM212	4.05e-04	199	40	4	5280_UP
Drug	TTNPB; Down 200; 0.1uM; MCF7; HG-U133A	DDX17 RUNX1 NFAT5 SGTA	4.05e-04	199	40	4	223_DN
Drug	celecoxib; Up 200; 10uM; MCF7; HG-U133A	HNF1A ALPK1 RUNX1 MN1	4.12e-04	200	40	4	252_UP
Drug	Nadolol [42200-33-9]; Down 200; 13uM; HL60; HT_HG-U133A	NCOA1 ZFHX3 RUNX1 CLOCK	4.12e-04	200	40	4	3020_DN
Drug	Diloxanide furoate [3736-81-0]; Down 200; 12.2uM; PC3; HT_HG-U133A	NCOA1 ALPK1 SOCS6 NFAT5	4.12e-04	200	40	4	6679_DN
Drug	1,3-bis(4-hydroxyphenyl)-4-methyl-5-(4-(2-piperidinylethoxy)phenol)-1H-pyrazole	NCOA1 CREBBP	4.52e-04	18	40	2	ctd:C524478
Disease	Prostatic Neoplasms	NCOA1 NCOA3 KMT2C ZFHX3 CHD7 RUNX1 CREBBP HERPUD1	1.47e-06	616	40	8	C0033578
Disease	Malignant neoplasm of prostate	NCOA1 NCOA3 KMT2C ZFHX3 CHD7 RUNX1 CREBBP HERPUD1	1.47e-06	616	40	8	C0376358
Disease	Abnormal corpus callosum morphology	MED12L MN1	2.68e-05	6	40	2	C1842581
Disease	phosphatidylcholine measurement	NCOA1 HNF1A ZFHX3 CHD7 HERPUD1	3.98e-05	284	40	5	EFO_0010226
Disease	lactosyl-N-nervonoyl-sphingosine (d18:1/24:1) measurement	CHD7 HERPUD1	6.41e-05	9	40	2	EFO_0800517
Disease	Leukemia, Myelocytic, Acute	KMT2C RUNX1 MN1 CREBBP	8.85e-05	173	40	4	C0023467
Disease	attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement	ZFHX3 ARID1B CHD7 NFAT5 MAML3 BEND7 TNRC6A	9.03e-05	801	40	7	EFO_0003888, EFO_0007052, MONDO_0002491
Disease	breast carcinoma (is_marker_for)	NCOA1 NCOA3 ZFHX3	9.95e-05	66	40	3	DOID:3459 (is_marker_for)
Disease	total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality, cancer	ZFHX3 HERPUD1 MAML3	1.14e-04	69	40	3	EFO_0000275, EFO_0000400, EFO_0000712, EFO_0001645, EFO_0003144, EFO_0004340, EFO_0004348, EFO_0004352, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928, MONDO_0004992
Disease	metabolic syndrome	HNF1A NFAT5 HERPUD1 TNRC6A	1.55e-04	200	40	4	EFO_0000195
Disease	C-reactive protein measurement	TRERF1 NCOA6 HNF1A CHD7 TAF4 NFAT5 HERPUD1 MAML3	1.82e-04	1206	40	8	EFO_0004458
Disease	Germ Cell Cancer	PHC1 BUB1B	1.86e-04	15	40	2	C0740345
Disease	Germ cell tumor	PHC1 BUB1B	1.86e-04	15	40	2	C0205851
Disease	Neoplasms, Embryonal and Mixed	PHC1 BUB1B	1.86e-04	15	40	2	C0205852
Disease	Embryonal Neoplasm	PHC1 BUB1B	1.86e-04	15	40	2	C0027654
Disease	Neoplasms, Germ Cell and Embryonal	PHC1 BUB1B	1.86e-04	15	40	2	C0027658
Disease	Cancer, Embryonal	PHC1 BUB1B	1.86e-04	15	40	2	C0751364
Disease	Cancer, Embryonal and Mixed	PHC1 BUB1B	1.86e-04	15	40	2	C0751365
Disease	Squamous cell carcinoma of esophagus	KMT2C CREBBP BUB1B	2.93e-04	95	40	3	C0279626
Disease	acute lymphoblastic leukemia, response to antineoplastic agent	NCOA3 MAML2	3.02e-04	19	40	2	EFO_0000220, GO_0097327
Disease	Adenoid Cystic Carcinoma	KMT2C CREBBP MAML3	3.41e-04	100	40	3	C0010606
Disease	hematocrit	HNF1A ARID1B MAML2 DDX17 RUNX1 NFAT5 BEND7	3.76e-04	1011	40	7	EFO_0004348
Disease	gallstones	HNF1A DDX17 NFAT5	4.27e-04	108	40	3	EFO_0004210
Disease	neutrophil count	SPRR4 TRERF1 NCOA1 HNF1A CHD7 CREBBP BEND7 TNRC6A	4.57e-04	1382	40	8	EFO_0004833
Disease	diet measurement	NCOA6 ZFHX3 ARID1B ALPK1 RUNX1 MAML3 TNRC6A	4.70e-04	1049	40	7	EFO_0008111
Disease	Malignant neoplasm of breast	TRERF1 NCOA1 NCOA3 NCOA6 ARID1B USP54 BEND7	5.41e-04	1074	40	7	C0006142
Disease	Sezary Syndrome	KMT2C CREBBP	6.16e-04	27	40	2	C0036920
Disease	Acute Myeloid Leukemia, M1	KMT2C RUNX1 MN1	6.54e-04	125	40	3	C0026998
Disease	Acute Myeloid Leukemia (AML-M2)	KMT2C RUNX1 MN1	6.54e-04	125	40	3	C1879321
Disease	chloride measurement	HNF1A NFAT5	7.11e-04	29	40	2	EFO_0009284
Disease	cholesterol to total lipids in very large HDL percentage	HNF1A HERPUD1	8.13e-04	31	40	2	EFO_0022243
Disease	smoking status measurement	MED12L ZFHX3 CHD7 NFAT5 MAML3 BEND7 TNRC6A	8.52e-04	1160	40	7	EFO_0006527
Disease	lung non-small cell carcinoma (is_implicated_in)	KMT2C ZFHX3 ARID1B	8.90e-04	139	40	3	DOID:3908 (is_implicated_in)
Disease	smoking cessation	ZFHX3 NFAT5 MAML3 TNRC6A	9.66e-04	325	40	4	EFO_0004319
Disease	autism spectrum disorder (implicated_via_orthology)	ARID1B CHD7 CREBBP	1.15e-03	152	40	3	DOID:0060041 (implicated_via_orthology)
Disease	waist-hip ratio	RUNX1 NFAT5 CLOCK MN1 MAML3 PHC1 TNRC6A	1.18e-03	1226	40	7	EFO_0004343
Disease	prostate cancer (is_marker_for)	NCOA1 NCOA3 KMT2C	1.24e-03	156	40	3	DOID:10283 (is_marker_for)
Disease	cholesterol in very small VLDL measurement	HNF1A HERPUD1	1.35e-03	40	40	2	EFO_0022231

Protein segments in the cluster

Peptide	Gene	Start	Entry
RGLQNPFPQQMQNNS	BUB1B	256	O60566
QQQPQQQPGEAYSAM	AMOT	396	Q4VCS5
LNNVSPINAMGNCNN	AFF2	1216	P51816
GQQPAQPQTHQQMRT	CREBBP	506	Q92793
PSQSQQRYQPQQDMS	ARID1B	701	Q8NFD5
SQQVMPYNPQQMGQQ	C1orf94	506	Q6P1W5
MNQQNPQAPQAQSLG	CSTF2	221	P33240
QQHGQPQQRMSQFSQ	CHD7	201	Q9P2D1
DNLEPSQNQPQQQMP	ALPK1	656	Q96QP1
SQNQPQQQMPLTPFS	ALPK1	661	Q96QP1
VNPGANQNLRMNAQG	HERPUD1	236	Q15011
LNNSQMNNPVGLPQH	KMT2C	2526	Q8NEZ4
LGPLQQSPQHQQQMG	KMT2C	3466	Q8NEZ4
QSQTLGLQAMQPQQP	MED12L	2086	Q86YW9
AFNNQNPIVPPMANN	MAML3	546	Q96JK9
NMINQQPNNLGTNSL	MAML3	576	Q96JK9
QTSPGLNQQPQNLIM	HNF1A	391	P20823
APMNQEQQPMQFQSQ	NFAT5	1316	O94916
PENGNPQQMQQELQR	NUP155	751	O75694
QANQQMPSVLPSQNK	MAML2	566	Q8IZL2
VNQTQQQMGPRPPQN	NCOA6	446	Q14686
QQGNVPPNFMVMQQQ	NCOA6	481	Q14686
VPQVNLSNMQGQPQQ	NCOA6	601	Q14686
QQFNTQNQSNVMPGP	NCOA6	726	Q14686
MQIQAVGTQNRQQPP	BEND7	186	Q8N7W2
GQQPQPLMSQQFAQP	DDX17	686	Q92841
SKMHAQPPQQQPQQQ	MN1	286	Q10571
SQNVNMPNQHFRQNP	PYGO1	166	Q9Y3Y4
AFNPQPQSQMQDTRQ	RUNX1	231	Q01196
QNPTNIQNFQLPPGM	TAF4	441	O00268
PQNLNTDGPNNTNPM	TNRC6C	176	Q9HCJ0
NSGAAQARTMQQPPQ	TNRC6C	1081	Q9HCJ0
AGQQFAQQMQQQNPE	SGTA	276	O43765
GNNQNQGNMQREPNQ	TARDBP	351	Q13148
QFGTGINPQMQQNVF	NCOA1	1216	Q15788
QPQVSSQQGFLNAQM	NCOA3	1211	Q9Y6Q9
NDPNRGNQVQRPQMT	SSX3	86	Q99909
QGLQMFLQQSNPGLN	CLOCK	561	O15516
RMNGQLQLPTNSGNN	USP27X	346	A6NNY8
QNGHINMQLPAGNPN	TMEM212	176	A6NML5
MSSQQQQRQQQQCPP	SPRR4	1	Q96PI1
RNQQASAQGPQMQGS	PHC1	211	P78364
PMQNNQIQRNFSGLT	SOCS6	316	O14544
QNLNSVRQNGNPSMF	TNRC6A	1321	Q8NDV7
QQQGMFDNTPLQALN	ZFHX3	3096	Q15911
LQDRMQQQQSPQQPS	USP54	861	Q70EL1
PPQQQQQAGQQRISM	TRERF1	271	Q96PN7